KR100842698B1 - 1,2,3,4-테트라하이드로이소퀴놀린 유도체 - Google Patents
1,2,3,4-테트라하이드로이소퀴놀린 유도체 Download PDFInfo
- Publication number
- KR100842698B1 KR100842698B1 KR1020027011533A KR20027011533A KR100842698B1 KR 100842698 B1 KR100842698 B1 KR 100842698B1 KR 1020027011533 A KR1020027011533 A KR 1020027011533A KR 20027011533 A KR20027011533 A KR 20027011533A KR 100842698 B1 KR100842698 B1 KR 100842698B1
- Authority
- KR
- South Korea
- Prior art keywords
- dimethoxy
- benzyl
- acetamide
- dihydro
- isoquinolin
- Prior art date
Links
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical class C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 title abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 68
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 229940123730 Orexin receptor antagonist Drugs 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims description 145
- -1 trifluoromethoxy, amino Chemical group 0.000 claims description 77
- 125000000217 alkyl group Chemical group 0.000 claims description 55
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000003342 alkenyl group Chemical group 0.000 claims description 23
- 125000000623 heterocyclic group Chemical group 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 23
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 19
- 239000001257 hydrogen Substances 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 102000002512 Orexin Human genes 0.000 claims description 13
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 108060005714 orexin Proteins 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 208000008589 Obesity Diseases 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 235000020824 obesity Nutrition 0.000 claims description 5
- 208000019116 sleep disease Diseases 0.000 claims description 5
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims description 4
- 125000006185 3,4-dimethyl benzyl group Chemical group [H]C1=C(C([H])=C(C(=C1[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 229920006395 saturated elastomer Chemical group 0.000 claims description 4
- RTCVKRBTBBZWQK-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-8-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC(C)C)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 RTCVKRBTBBZWQK-UHFFFAOYSA-N 0.000 claims description 3
- ULWOQYXTZAOOPO-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 ULWOQYXTZAOOPO-UHFFFAOYSA-N 0.000 claims description 3
- BPPYYMZLRANARW-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1-phenylethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC(C)C1=CC=CC=C1 BPPYYMZLRANARW-UHFFFAOYSA-N 0.000 claims description 3
- BFYOCLKGJYHCMY-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical class C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC2=CC=CC=C12 BFYOCLKGJYHCMY-UHFFFAOYSA-N 0.000 claims description 3
- LHFABXXKENNWII-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 LHFABXXKENNWII-UHFFFAOYSA-N 0.000 claims description 3
- CLZNMUKOZIHXLQ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methylphenyl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1C CLZNMUKOZIHXLQ-UHFFFAOYSA-N 0.000 claims description 3
- NBICEVBGTVHJCK-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(3-methylphenyl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC(C)=C1 NBICEVBGTVHJCK-UHFFFAOYSA-N 0.000 claims description 3
- JOFJQVWIZBJLIW-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-fluorophenyl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=C(F)C=C1 JOFJQVWIZBJLIW-UHFFFAOYSA-N 0.000 claims description 3
- VOOAWEFAVCKUTD-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(6-methoxynaphthalen-2-yl)methyl]acetamide Chemical compound C1=CC2=CC(OC)=CC=C2C=C1CNC(=O)CN1CCC2=CC(OC)=C(OC)C=C2C1CC1=CC=C(OC)C(OC)=C1 VOOAWEFAVCKUTD-UHFFFAOYSA-N 0.000 claims description 3
- HPTFIROIMUOFFN-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1C HPTFIROIMUOFFN-UHFFFAOYSA-N 0.000 claims description 3
- JHOUZBOSKGWUGT-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(4-methyl-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C(C=CC=C2C)=C2CC1 JHOUZBOSKGWUGT-UHFFFAOYSA-N 0.000 claims description 3
- KWKCDWGGCNCEJD-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(5-methoxy-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1CC2=CC(OC)=CC=C2C1NC(=O)CN1CCC2=CC(OC)=C(OC(C)C)C=C2C1CC1=CC=C(OC)C(OC)=C1 KWKCDWGGCNCEJD-UHFFFAOYSA-N 0.000 claims description 3
- OQRJGOYJLOXEFI-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(6-methoxy-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C12=CC(OC)=CC=C2CCC1NC(=O)CN1CCC2=CC(OC)=C(OC(C)C)C=C2C1CC1=CC=C(OC)C(OC)=C1 OQRJGOYJLOXEFI-UHFFFAOYSA-N 0.000 claims description 3
- UHKYYNCLIHROOK-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(6-methyl-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC(C)=CC=C2CC1 UHKYYNCLIHROOK-UHFFFAOYSA-N 0.000 claims description 3
- BQDWGGIKQHNCJP-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-8-(2-fluoroethoxy)-5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OCCF)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 BQDWGGIKQHNCJP-UHFFFAOYSA-N 0.000 claims description 3
- HMXPWIAPDVKQFN-UHFFFAOYSA-N 2-[7-(2,2-difluoroethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCC(F)F)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 HMXPWIAPDVKQFN-UHFFFAOYSA-N 0.000 claims description 3
- INANPRLITZJRSL-UHFFFAOYSA-N 2-[7-butan-2-yloxy-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1CC2=CC=CC=C2C1NC(=O)CN1CCC=2C=C(OC)C(OC(C)CC)=CC=2C1CC1=CC=C(OC)C(OC)=C1 INANPRLITZJRSL-UHFFFAOYSA-N 0.000 claims description 3
- IXIVCTNVUGDCGG-UHFFFAOYSA-N 2-[8-(2,2-difluoroethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OCC(F)F)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 IXIVCTNVUGDCGG-UHFFFAOYSA-N 0.000 claims description 3
- BVPKSCZDEKFXBF-UHFFFAOYSA-N 2-[8-(cyclopropylmethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OCC3CC3)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 BVPKSCZDEKFXBF-UHFFFAOYSA-N 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- WCUNEUHOXVBOIJ-UHFFFAOYSA-N [2-[2-(2,3-dihydro-1h-inden-1-ylamino)-2-oxoethyl]-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-7-yl] n,n-dimethylcarbamate Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(=O)N(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 WCUNEUHOXVBOIJ-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- SGHBDLOMRUXKQF-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 SGHBDLOMRUXKQF-UHFFFAOYSA-N 0.000 claims description 3
- CWKNFABKWPZSHN-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-pyrazin-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC=3N=CC=NC=3)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 CWKNFABKWPZSHN-UHFFFAOYSA-N 0.000 claims description 3
- INTXFZVWAFGXRO-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-(3-fluoropropoxy)-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCCCF)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 INTXFZVWAFGXRO-UHFFFAOYSA-N 0.000 claims description 3
- AVKSWJBBMWMGSZ-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-diethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(CC)C(CC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 AVKSWJBBMWMGSZ-UHFFFAOYSA-N 0.000 claims description 3
- FYSUZYYFUUADES-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 FYSUZYYFUUADES-UHFFFAOYSA-N 0.000 claims description 3
- DLZVDBYNJQVSNK-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 DLZVDBYNJQVSNK-UHFFFAOYSA-N 0.000 claims description 3
- BDOGXRJYDQNFQH-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1CNC(=O)CN1CCC=2C=C(OC)C(OCCC)=CC=2C1CC1=CC=C(OC)C(OC)=C1 BDOGXRJYDQNFQH-UHFFFAOYSA-N 0.000 claims description 3
- FSBQTAPUGFUXPA-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-ethoxy-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1CNC(=O)CN1CCC=2C=C(OC)C(OCC)=CC=2C1CC1=CC=C(OC)C(OC)=C1 FSBQTAPUGFUXPA-UHFFFAOYSA-N 0.000 claims description 3
- RRBYCHHICVPEJB-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(3-methoxy-4-pyrimidin-2-yloxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC=2N=CC=CN=2)C(OC)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 RRBYCHHICVPEJB-UHFFFAOYSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 229910052717 sulfur Chemical group 0.000 claims description 3
- 239000011593 sulfur Chemical group 0.000 claims description 3
- NMIADDOCHFQYMI-UHFFFAOYSA-N 2-[1-[(3,4-diethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(CC)C(CC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=N1 NMIADDOCHFQYMI-UHFFFAOYSA-N 0.000 claims description 2
- SUWULIOJNWIAFZ-UHFFFAOYSA-N 2-[1-[(3,4-diethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-3-ylmethyl)acetamide Chemical compound C1=C(CC)C(CC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CN=C1 SUWULIOJNWIAFZ-UHFFFAOYSA-N 0.000 claims description 2
- YHOZFZRJFBWWMD-UHFFFAOYSA-N 2-[1-[(3,4-diethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-4-ylmethyl)acetamide Chemical compound C1=C(CC)C(CC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=NC=C1 YHOZFZRJFBWWMD-UHFFFAOYSA-N 0.000 claims description 2
- GCQCVZZGKIKVTL-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 GCQCVZZGKIKVTL-UHFFFAOYSA-N 0.000 claims description 2
- JWMZPZFSAXVGMK-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(6-methoxy-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C12=CC(OC)=CC=C2CCC1NC(=O)CN1CCC2=CC(OC)=C(OC)C=C2C1CC1=CC=C(OC)C(OC)=C1 JWMZPZFSAXVGMK-UHFFFAOYSA-N 0.000 claims description 2
- TWERMHZJLOWSCE-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(6-methyl-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC(C)=CC=C2CC1 TWERMHZJLOWSCE-UHFFFAOYSA-N 0.000 claims description 2
- LEAOUHNQDQTSAG-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-methoxynaphthalen-2-yl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC(OC)=C(C=CC=C2)C2=C1 LEAOUHNQDQTSAG-UHFFFAOYSA-N 0.000 claims description 2
- UHOHUDAKXCCXRE-UHFFFAOYSA-N 2-[7-(2-cyclopropylethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl]-N-(2,3-dihydro-1H-inden-1-yl)acetamide Chemical compound COC1=C(C=C(C=C1)CC2C3=CC(=C(C=C3CCN2CC(=O)NC4CCC5=CC=CC=C45)OC)OCCC6CC6)OC UHOHUDAKXCCXRE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 238000006482 condensation reaction Methods 0.000 claims description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 2
- JSTPLZSRDPUNTH-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-(1,3-thiazol-2-yloxy)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC=3SC=CN=3)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 JSTPLZSRDPUNTH-UHFFFAOYSA-N 0.000 claims description 2
- JEQKCODCUDURBW-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 JEQKCODCUDURBW-UHFFFAOYSA-N 0.000 claims description 2
- 238000005580 one pot reaction Methods 0.000 claims description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims 2
- 125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 419
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 243
- 238000006243 chemical reaction Methods 0.000 description 195
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 59
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 50
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 33
- YXWQTVWJNHKSCC-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1 YXWQTVWJNHKSCC-UHFFFAOYSA-N 0.000 description 31
- 239000000203 mixture Substances 0.000 description 31
- 238000007363 ring formation reaction Methods 0.000 description 31
- WMWYGDZKGRHADI-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1 WMWYGDZKGRHADI-UHFFFAOYSA-N 0.000 description 28
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 27
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000002904 solvent Substances 0.000 description 21
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 150000001412 amines Chemical class 0.000 description 18
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000008346 aqueous phase Substances 0.000 description 15
- 239000000460 chlorine Substances 0.000 description 15
- ANWKSRMTENFMAJ-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1 ANWKSRMTENFMAJ-UHFFFAOYSA-N 0.000 description 14
- YXWQTVWJNHKSCC-INIZCTEOSA-N (1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1 YXWQTVWJNHKSCC-INIZCTEOSA-N 0.000 description 13
- ZWXFFJWOZVUYKB-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1 ZWXFFJWOZVUYKB-UHFFFAOYSA-N 0.000 description 13
- HSNRSHBFNHIQQL-UHFFFAOYSA-N 6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=CC2=CC(CC3NCCC=4C=C(C(=CC=43)OC)OC)=CC=C21 HSNRSHBFNHIQQL-UHFFFAOYSA-N 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 12
- YNDQAFGFNLWXQB-UHFFFAOYSA-N n-benzyl-2-[1-[(4-hydroxy-3-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(O)C(OC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 YNDQAFGFNLWXQB-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- XASGBYOFEJTAPK-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CCC=2C(OC)=CC=C(OC)C=2C1CC1=CC=C(OC)C(OC)=C1 XASGBYOFEJTAPK-UHFFFAOYSA-N 0.000 description 11
- DQLMJULGOGAQCH-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C(OC)=CC(OC)=CC=2CCNC1CC1=CC=C(OC)C(OC)=C1 DQLMJULGOGAQCH-UHFFFAOYSA-N 0.000 description 11
- KPWTVVBDJMLSJG-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 KPWTVVBDJMLSJG-UHFFFAOYSA-N 0.000 description 11
- HWNSTGWDEVWFNH-UHFFFAOYSA-N 1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=CC=C1 HWNSTGWDEVWFNH-UHFFFAOYSA-N 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 11
- ZJLMETHEORLUCQ-UHFFFAOYSA-N n-benzyl-2-[1-[(3-hydroxy-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(O)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 ZJLMETHEORLUCQ-UHFFFAOYSA-N 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- PXJACNDVRNAFHD-UHFFFAOYSA-N (2-methoxyphenyl)methanamine Chemical compound COC1=CC=CC=C1CN PXJACNDVRNAFHD-UHFFFAOYSA-N 0.000 description 10
- QBJIMTPENIGDOG-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(CC(Cl)=O)C=C1OC QBJIMTPENIGDOG-UHFFFAOYSA-N 0.000 description 10
- NCBLMBAELRCUHD-UHFFFAOYSA-N 6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(OC)C(OC)=C1OC NCBLMBAELRCUHD-UHFFFAOYSA-N 0.000 description 10
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- 238000003818 flash chromatography Methods 0.000 description 10
- LAUPTNYHVCVPFH-UHFFFAOYSA-N (2-ethoxyphenyl)methanamine Chemical compound CCOC1=CC=CC=C1CN LAUPTNYHVCVPFH-UHFFFAOYSA-N 0.000 description 9
- SRKDGMYMABXBMA-UHFFFAOYSA-N 1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2)=C1 SRKDGMYMABXBMA-UHFFFAOYSA-N 0.000 description 9
- BGXHKISGQNWFOY-UHFFFAOYSA-N 4-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-n,n-dimethylaniline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(N(C)C)C=C1 BGXHKISGQNWFOY-UHFFFAOYSA-N 0.000 description 9
- NRJCAOCPBSXOGP-UHFFFAOYSA-N 6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2)=C1 NRJCAOCPBSXOGP-UHFFFAOYSA-N 0.000 description 9
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- FIPKSKMDTAQBDJ-UHFFFAOYSA-N 1-methyl-2,3-dihydro-1h-indene Chemical compound C1=CC=C2C(C)CCC2=C1 FIPKSKMDTAQBDJ-UHFFFAOYSA-N 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- HSGSJIIJCGUGLY-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-hydroxy-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C=C(O)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 HSGSJIIJCGUGLY-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- YSOCJYPSQCCGNA-UHFFFAOYSA-N 1-[(3-bromo-4-methoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(Br)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1 YSOCJYPSQCCGNA-UHFFFAOYSA-N 0.000 description 7
- MOOMGAOQWHKDSC-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(Cl)C=C1 MOOMGAOQWHKDSC-UHFFFAOYSA-N 0.000 description 7
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 7
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000012981 Hank's balanced salt solution Substances 0.000 description 7
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 7
- 239000005557 antagonist Substances 0.000 description 7
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 7
- 238000010511 deprotection reaction Methods 0.000 description 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 7
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 7
- ACOHAEBNFWGQCL-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)acetamide Chemical compound CC(=O)NCC1=CC=CC=N1 ACOHAEBNFWGQCL-UHFFFAOYSA-N 0.000 description 7
- GQMVLTNYCPDBLP-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-hydroxy-7-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1CNC(=O)CN1CCC=2C=C(O)C(OC)=CC=2C1CC1=CC=C(OC)C(OC)=C1 GQMVLTNYCPDBLP-UHFFFAOYSA-N 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 7
- 108020003175 receptors Proteins 0.000 description 7
- LRFWYBZWRQWZIM-UHFFFAOYSA-N (2-fluorophenyl)methanamine Chemical compound NCC1=CC=CC=C1F LRFWYBZWRQWZIM-UHFFFAOYSA-N 0.000 description 6
- JRZGPXSSNPTNMA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=CC=C2C(N)CCCC2=C1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 description 6
- PFYXGKHVNOPDHU-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-ylmethyl)-5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C2OCOC2=CC(CC2C=3C(OC)=CC=C(C=3CCN2)OC)=C1 PFYXGKHVNOPDHU-UHFFFAOYSA-N 0.000 description 6
- HOFWLPPBIBQUCV-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C2OCOC2=CC(CC2NCCC=3C=C(C(=CC=32)OC)OC)=C1 HOFWLPPBIBQUCV-UHFFFAOYSA-N 0.000 description 6
- FNSGPTFLDDASLF-UHFFFAOYSA-N 1-[(3,4-dimethylphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(C)C(C)=C1 FNSGPTFLDDASLF-UHFFFAOYSA-N 0.000 description 6
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
- LMHHFZAXSANGGM-UHFFFAOYSA-N 2-aminoindane Chemical compound C1=CC=C2CC(N)CC2=C1 LMHHFZAXSANGGM-UHFFFAOYSA-N 0.000 description 6
- GXTUEUWFEKEQHJ-UHFFFAOYSA-N 6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1 GXTUEUWFEKEQHJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 6
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 6
- YRYCIFUZSUMAAY-UHFFFAOYSA-N (RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CCC2=CC=CC=C2C1CC1=CC=CC=C1 YRYCIFUZSUMAAY-UHFFFAOYSA-N 0.000 description 5
- IGWXUFJDUPHOHK-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(F)C=C1 IGWXUFJDUPHOHK-UHFFFAOYSA-N 0.000 description 5
- VNHWPVLQRKKKRY-UHFFFAOYSA-N 1-bromo-3-fluoropropane Chemical compound FCCCBr VNHWPVLQRKKKRY-UHFFFAOYSA-N 0.000 description 5
- KMGCKSAIIHOKCX-UHFFFAOYSA-N 2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2CC(O)CC2=C1 KMGCKSAIIHOKCX-UHFFFAOYSA-N 0.000 description 5
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 5
- FPWLTKFZPJGKSX-UHFFFAOYSA-N 2-methoxy-2-(3-methoxyphenyl)ethanamine Chemical compound COC(CN)C1=CC=CC(OC)=C1 FPWLTKFZPJGKSX-UHFFFAOYSA-N 0.000 description 5
- 239000007995 HEPES buffer Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 102000008834 Orexin receptor Human genes 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- AKEYUWUEAXIBTF-UHFFFAOYSA-N n-methylnaphthalen-1-amine Chemical compound C1=CC=C2C(NC)=CC=CC2=C1 AKEYUWUEAXIBTF-UHFFFAOYSA-N 0.000 description 5
- 239000010502 orange oil Substances 0.000 description 5
- OFNHNCAUVYOTPM-IIIOAANCSA-N orexin-a Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N2)[C@@H](C)O)=O)CSSC1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1NC(=O)CC1)C1=CNC=N1 OFNHNCAUVYOTPM-IIIOAANCSA-N 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 4
- FEBIPJYPQVUYPH-UHFFFAOYSA-N 1-[(3,4-diethylphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(CC)C(CC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1 FEBIPJYPQVUYPH-UHFFFAOYSA-N 0.000 description 4
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 4
- UPSXAPQYNGXVBF-UHFFFAOYSA-N 2-bromobutane Chemical compound CCC(C)Br UPSXAPQYNGXVBF-UHFFFAOYSA-N 0.000 description 4
- ZSTCPHVBMNDKEB-UHFFFAOYSA-N 6,7-dimethoxy-1-(2-phenylethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CCC1=CC=CC=C1 ZSTCPHVBMNDKEB-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- XTUVJUMINZSXGF-UHFFFAOYSA-N N-methylcyclohexylamine Chemical compound CNC1CCCCC1 XTUVJUMINZSXGF-UHFFFAOYSA-N 0.000 description 4
- 150000001347 alkyl bromides Chemical class 0.000 description 4
- 150000001408 amides Chemical group 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000002527 isonitriles Chemical class 0.000 description 4
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- KDDNKZCVYQDGKE-UHFFFAOYSA-N (2-chlorophenyl)methanamine Chemical compound NCC1=CC=CC=C1Cl KDDNKZCVYQDGKE-UHFFFAOYSA-N 0.000 description 3
- CJAAPVQEZPAQNI-UHFFFAOYSA-N (2-methylphenyl)methanamine Chemical compound CC1=CC=CC=C1CN CJAAPVQEZPAQNI-UHFFFAOYSA-N 0.000 description 3
- RGXUCUWVGKLACF-UHFFFAOYSA-N (3-methylphenyl)methanamine Chemical compound CC1=CC=CC(CN)=C1 RGXUCUWVGKLACF-UHFFFAOYSA-N 0.000 description 3
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 3
- JPQWLBDPQWBRPV-UHFFFAOYSA-N 1-[(3,4-dichlorophenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(Cl)C(Cl)=C1 JPQWLBDPQWBRPV-UHFFFAOYSA-N 0.000 description 3
- VMPLLPIDRGXFTQ-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;hydrochloride Chemical compound [Cl-].C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CC[NH2+]1 VMPLLPIDRGXFTQ-UHFFFAOYSA-N 0.000 description 3
- RZUZZVWHTNDQOV-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-phenylmethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCC=3C=CC=CC=3)=C(OC)C=C2CCN1 RZUZZVWHTNDQOV-UHFFFAOYSA-N 0.000 description 3
- LOPKSXMQWBYUOI-UHFFFAOYSA-N 1-amino-2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2C(N)C(O)CC2=C1 LOPKSXMQWBYUOI-UHFFFAOYSA-N 0.000 description 3
- VXRWKBITZHUSQW-UHFFFAOYSA-N 1-benzhydryl-5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CCC=2C(OC)=CC=C(OC)C=2C1C(C=1C=CC=CC=1)C1=CC=CC=C1 VXRWKBITZHUSQW-UHFFFAOYSA-N 0.000 description 3
- JTLAIKFGRHDNQM-UHFFFAOYSA-N 1-bromo-2-fluoroethane Chemical compound FCCBr JTLAIKFGRHDNQM-UHFFFAOYSA-N 0.000 description 3
- JVYROUWXXSWCMI-UHFFFAOYSA-N 2-bromo-1,1-difluoroethane Chemical compound FC(F)CBr JVYROUWXXSWCMI-UHFFFAOYSA-N 0.000 description 3
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 description 3
- IGPYNHMMDJOIQN-UHFFFAOYSA-N 6,7-dimethoxy-1-(1-phenylpropyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CCC2=CC(OC)=C(OC)C=C2C1C(CC)C1=CC=CC=C1 IGPYNHMMDJOIQN-UHFFFAOYSA-N 0.000 description 3
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical class NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 3
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 3
- 208000004454 Hyperalgesia Diseases 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 108050000742 Orexin Receptor Proteins 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical compound C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 description 3
- BDHXJXFAAXZERV-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-(hydroxymethyl)-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1CC2=CC=CC=C2C1NC(=O)CN1CCC(C=C(C(=C2)OC)OC)=C2C1CO BDHXJXFAAXZERV-UHFFFAOYSA-N 0.000 description 3
- KQZCRXVJXGYIFM-UHFFFAOYSA-N n-(pyridin-3-ylmethyl)acetamide Chemical compound CC(=O)NCC1=CC=CN=C1 KQZCRXVJXGYIFM-UHFFFAOYSA-N 0.000 description 3
- 201000003631 narcolepsy Diseases 0.000 description 3
- 208000004296 neuralgia Diseases 0.000 description 3
- 239000012038 nucleophile Substances 0.000 description 3
- OHOWSYIKESXDMN-WMQZXSDYSA-N orexin-b Chemical compound C([C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)C1=CNC=N1 OHOWSYIKESXDMN-WMQZXSDYSA-N 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229940044551 receptor antagonist Drugs 0.000 description 3
- 239000002464 receptor antagonist Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GDFBHCMFIUBEQT-UHFFFAOYSA-N (2,5-difluorophenyl)methanamine Chemical compound NCC1=CC(F)=CC=C1F GDFBHCMFIUBEQT-UHFFFAOYSA-N 0.000 description 2
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 2
- UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- HYHOBLFHBFTVGR-UHFFFAOYSA-N 1-[(2,5-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound COC1=CC=C(OC)C(CC2C3=CC(OC)=C(OC)C=C3CCN2)=C1 HYHOBLFHBFTVGR-UHFFFAOYSA-N 0.000 description 2
- XUGXVRXTSBIUON-UHFFFAOYSA-N 1-[(3,4-difluorophenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC=C(F)C(F)=C1 XUGXVRXTSBIUON-UHFFFAOYSA-N 0.000 description 2
- WKMNJFHMNUVFSX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-8-phenylmethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C(CC=3C=C(OC)C(OC)=CC=3)NCCC=2C(OC)=CC=C1OCC1=CC=CC=C1 WKMNJFHMNUVFSX-UHFFFAOYSA-N 0.000 description 2
- HLIQXYYZPCEECQ-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-7-methoxy-6-phenylmethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OCC=3C=CC=CC=3)C=C2CCN1 HLIQXYYZPCEECQ-UHFFFAOYSA-N 0.000 description 2
- XMKIJBZKRPJLGX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-8-methoxy-5-phenylmethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OCC=3C=CC=CC=3)=C2CCN1 XMKIJBZKRPJLGX-UHFFFAOYSA-N 0.000 description 2
- JXBGBNUEKURSRY-UHFFFAOYSA-N 1-benzyl-5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound N1CCC=2C(OC)=CC=C(OC)C=2C1CC1=CC=CC=C1 JXBGBNUEKURSRY-UHFFFAOYSA-N 0.000 description 2
- OOXOWBLOFXAPBK-UHFFFAOYSA-N 1-methoxy-2,3-dihydro-1h-indene Chemical compound C1=CC=C2C(OC)CCC2=C1 OOXOWBLOFXAPBK-UHFFFAOYSA-N 0.000 description 2
- RPDXVMBCIRAVCV-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-n-[2-(3,4-dimethoxyphenyl)ethyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(OCO2)C2=C1 RPDXVMBCIRAVCV-UHFFFAOYSA-N 0.000 description 2
- ODVLMCWNGKLROU-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2OCOC2=C1 ODVLMCWNGKLROU-UHFFFAOYSA-N 0.000 description 2
- YSSRPZDIPQMYDW-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=C(OC)C(CC(=O)NCCC=2C=C(OC)C(OC)=CC=2)=C1 YSSRPZDIPQMYDW-UHFFFAOYSA-N 0.000 description 2
- RAPIPBRHRYSAHQ-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(OC)C(CC(Cl)=O)=C1 RAPIPBRHRYSAHQ-UHFFFAOYSA-N 0.000 description 2
- AAQIRQUMPMWERW-UHFFFAOYSA-N 2-(3,4-difluorophenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(F)C(F)=C1 AAQIRQUMPMWERW-UHFFFAOYSA-N 0.000 description 2
- WKMPNMHAVRYZFG-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(3-methoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=CC(CCNC(=O)CC=2C=C(OC)C(OC)=CC=2)=C1 WKMPNMHAVRYZFG-UHFFFAOYSA-N 0.000 description 2
- XPHIFDXVOGTFLO-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(Cl)C=C1 XPHIFDXVOGTFLO-UHFFFAOYSA-N 0.000 description 2
- WGNLEWXWKBBWBL-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 WGNLEWXWKBBWBL-UHFFFAOYSA-N 0.000 description 2
- BHEYKGOHDCGAFD-UHFFFAOYSA-N 2-[1-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]-2h-pyrimidin-2-yl]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCC1N1C(CC(O)=O)N=CC=C1 BHEYKGOHDCGAFD-UHFFFAOYSA-N 0.000 description 2
- IGIXENPZYHUOEF-UHFFFAOYSA-N 2-[1-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]cyclohexa-2,4-dien-1-yl]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCC1C1(CC(O)=O)C=CC=CC1 IGIXENPZYHUOEF-UHFFFAOYSA-N 0.000 description 2
- JUIKUQOUMZUFQT-UHFFFAOYSA-N 2-bromoacetamide Chemical compound NC(=O)CBr JUIKUQOUMZUFQT-UHFFFAOYSA-N 0.000 description 2
- RUJHATQMIMUYKD-UHFFFAOYSA-N 2-naphthalen-1-ylethanamine Chemical compound C1=CC=C2C(CCN)=CC=CC2=C1 RUJHATQMIMUYKD-UHFFFAOYSA-N 0.000 description 2
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 2
- FUTZESSLBXJDFG-UHFFFAOYSA-N 4-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2)=C1 FUTZESSLBXJDFG-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- YQTZICLOPZEECN-UHFFFAOYSA-N 6,7-dimethoxy-1-(phenylmethoxymethyl)-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1COCC1=CC=CC=C1 YQTZICLOPZEECN-UHFFFAOYSA-N 0.000 description 2
- IYDXQGNUXUOZOC-UHFFFAOYSA-N 6,7-dimethoxy-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNC1CC1=CC(OC)=C(OC)C(OC)=C1 IYDXQGNUXUOZOC-UHFFFAOYSA-N 0.000 description 2
- OIMFNCWZUMIHMJ-UHFFFAOYSA-N 6,7-dimethoxy-1-[(4-methoxy-3-phenylmethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline Chemical compound COC1=CC=C(CC2C3=CC(OC)=C(OC)C=C3CCN2)C=C1OCC1=CC=CC=C1 OIMFNCWZUMIHMJ-UHFFFAOYSA-N 0.000 description 2
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- NATVYCXELOFPLE-UHFFFAOYSA-N CCC(CNCCC(C=C1)=CC(OC)=C1OC)C1=CC=CC=C1 Chemical compound CCC(CNCCC(C=C1)=CC(OC)=C1OC)C1=CC=CC=C1 NATVYCXELOFPLE-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- 101000598921 Homo sapiens Orexin Proteins 0.000 description 2
- 208000035154 Hyperesthesia Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 2
- 208000014993 Pituitary disease Diseases 0.000 description 2
- 206010051944 Pituitary hypoplasia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- AQNQQHJNRPDOQV-UHFFFAOYSA-N bromocyclohexane Chemical compound BrC1CCCCC1 AQNQQHJNRPDOQV-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 2
- XMWFMEYDRNJSOO-UHFFFAOYSA-N morpholine-4-carbonyl chloride Chemical compound ClC(=O)N1CCOCC1 XMWFMEYDRNJSOO-UHFFFAOYSA-N 0.000 description 2
- OPMIQHRZTXHFFJ-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-(2-fluoroethoxy)-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCCF)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 OPMIQHRZTXHFFJ-UHFFFAOYSA-N 0.000 description 2
- BZHHHCHIUFWNRT-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-hydroxy-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=2C=C(O)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1CC1=CC=C(OC)C(OC)=C1 BZHHHCHIUFWNRT-UHFFFAOYSA-N 0.000 description 2
- KHRSKAWKZAQREJ-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[6,7-dimethoxy-1-(phenylmethoxymethyl)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1COCC1=CC=CC=C1 KHRSKAWKZAQREJ-UHFFFAOYSA-N 0.000 description 2
- UYBJHVSZRXMCIQ-UHFFFAOYSA-N n-(cyclohexylmethyl)acetamide Chemical compound CC(=O)NCC1CCCCC1 UYBJHVSZRXMCIQ-UHFFFAOYSA-N 0.000 description 2
- MZCVTBJXTMEQLJ-UHFFFAOYSA-N n-(pyridin-4-ylmethyl)acetamide Chemical compound CC(=O)NCC1=CC=NC=C1 MZCVTBJXTMEQLJ-UHFFFAOYSA-N 0.000 description 2
- SGHBDLOMRUXKQF-UIOOFZCWSA-N n-[(1s)-2,3-dihydro-1h-inden-1-yl]-2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)N[C@@H]1C2=CC=CC=C2CC1 SGHBDLOMRUXKQF-UIOOFZCWSA-N 0.000 description 2
- HQDGRCBVDVPNBF-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(2,3,4-trimethoxyphenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(OC)C(OC)=C1OC HQDGRCBVDVPNBF-UHFFFAOYSA-N 0.000 description 2
- FGPUFQRNZGCKQV-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3,4,5-trimethoxyphenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC(OC)=C(OC)C(OC)=C1 FGPUFQRNZGCKQV-UHFFFAOYSA-N 0.000 description 2
- JXUNQKVJRZBSER-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NCCC=2C=C(OC)C(OC)=CC=2)=C1 JXUNQKVJRZBSER-UHFFFAOYSA-N 0.000 description 2
- FAMYMMVKOXQHTC-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(4-fluorophenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(F)C=C1 FAMYMMVKOXQHTC-UHFFFAOYSA-N 0.000 description 2
- FBMGZFDOFQXQKX-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(4-hydroxy-3-methoxyphenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(O)C(OC)=C1 FBMGZFDOFQXQKX-UHFFFAOYSA-N 0.000 description 2
- VXBDJWHXZMSPEZ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CC(=O)NCCC1=CC=C(OC)C(OC)=C1 VXBDJWHXZMSPEZ-UHFFFAOYSA-N 0.000 description 2
- HVABELWWEQMYIB-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=CC=C1 HVABELWWEQMYIB-UHFFFAOYSA-N 0.000 description 2
- NKTXVHNEQLENPU-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylmethoxyacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)COCC1=CC=CC=C1 NKTXVHNEQLENPU-UHFFFAOYSA-N 0.000 description 2
- XZQORMQJAFYPRT-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenylpropanamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CCC1=CC=CC=C1 XZQORMQJAFYPRT-UHFFFAOYSA-N 0.000 description 2
- HFXHCZBJZUJSCZ-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-phenylmethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCC=3C=CC=CC=3)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 HFXHCZBJZUJSCZ-UHFFFAOYSA-N 0.000 description 2
- JCMWNICXFYUVHB-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-methoxy-6-phenylmethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OCC=3C=CC=CC=3)C=C2CCN1CC(=O)NCC1=CC=CC=C1 JCMWNICXFYUVHB-UHFFFAOYSA-N 0.000 description 2
- SCYSJTVSIFCPEH-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(4-methoxy-3-phenylmethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OCC=2C=CC=CC=2)C(OC)=CC=C1CC(C1=CC(OC)=C(OC)C=C1CC1)N1CC(=O)NCC1=CC=CC=C1 SCYSJTVSIFCPEH-UHFFFAOYSA-N 0.000 description 2
- NVSYANRBXPURRQ-UHFFFAOYSA-N naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CN)=CC=CC2=C1 NVSYANRBXPURRQ-UHFFFAOYSA-N 0.000 description 2
- 208000021722 neuropathic pain Diseases 0.000 description 2
- 208000015238 neurotic disease Diseases 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- XJEVHMGJSYVQBQ-SECBINFHSA-N (1r)-2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2[C@H](N)CCC2=C1 XJEVHMGJSYVQBQ-SECBINFHSA-N 0.000 description 1
- XJEVHMGJSYVQBQ-VIFPVBQESA-N (1s)-2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2[C@@H](N)CCC2=C1 XJEVHMGJSYVQBQ-VIFPVBQESA-N 0.000 description 1
- LOPKSXMQWBYUOI-BDAKNGLRSA-N (1s,2r)-1-amino-2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2[C@H](N)[C@H](O)CC2=C1 LOPKSXMQWBYUOI-BDAKNGLRSA-N 0.000 description 1
- QOWBXWFYRXSBAS-UHFFFAOYSA-N (2,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C(OC)=C1 QOWBXWFYRXSBAS-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- HMTSWYPNXFHGEP-UHFFFAOYSA-N (4-methylphenyl)methanamine Chemical compound CC1=CC=C(CN)C=C1 HMTSWYPNXFHGEP-UHFFFAOYSA-N 0.000 description 1
- MCCAWZYURZFQOX-UHFFFAOYSA-N (6-methoxynaphthalen-2-yl)methanamine Chemical compound C1=C(CN)C=CC2=CC(OC)=CC=C21 MCCAWZYURZFQOX-UHFFFAOYSA-N 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- 0 *C(C(N*)=*)N(CC1)C(*)c(cc2*)c1cc2I* Chemical compound *C(C(N*)=*)N(CC1)C(*)c(cc2*)c1cc2I* 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- MJUVRTYWUMPBTR-MRXNPFEDSA-N 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-n-[1-[(2r)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide Chemical compound FC=1C=C2N(C[C@@H](O)CO)C(C(C)(CO)C)=CC2=CC=1NC(=O)C1(C=2C=C3OC(F)(F)OC3=CC=2)CC1 MJUVRTYWUMPBTR-MRXNPFEDSA-N 0.000 description 1
- QNWQFDSEWXFEIQ-UHFFFAOYSA-N 1-(3,4-dihydro-1h-isoquinolin-2-yl)-2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]ethanone Chemical compound C1=CC=CC2=CC(CC3N(CC(=O)N4CC5=CC=CC=C5CC4)CCC=4C=C(C(=CC=43)OC)OC)=CC=C21 QNWQFDSEWXFEIQ-UHFFFAOYSA-N 0.000 description 1
- FWIDZCMQCGNXCP-UHFFFAOYSA-N 1-[(4-bromo-3-methoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1=C(Br)C(OC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2)=C1 FWIDZCMQCGNXCP-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- BVMGTUJYIOYCBX-UHFFFAOYSA-N 1-bromo-2,3-dihydro-1h-indene Chemical compound C1=CC=C2C(Br)CCC2=C1 BVMGTUJYIOYCBX-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- VNAFWALXWOAPCK-UHFFFAOYSA-N 1-phenyl-2,3-dihydro-1h-indene Chemical compound C1CC2=CC=CC=C2C1C1=CC=CC=C1 VNAFWALXWOAPCK-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- KEJFADGISRFLFO-UHFFFAOYSA-N 1H-indazol-6-amine Chemical compound NC1=CC=C2C=NNC2=C1 KEJFADGISRFLFO-UHFFFAOYSA-N 0.000 description 1
- MSYLETHDEIJMAF-UHFFFAOYSA-N 2,2-diphenylacetyl chloride Chemical compound C=1C=CC=CC=1C(C(=O)Cl)C1=CC=CC=C1 MSYLETHDEIJMAF-UHFFFAOYSA-N 0.000 description 1
- XEHNLVMHWYPNEQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-2-amine;hydron;chloride Chemical compound Cl.C1=CC=C2CC(N)CC2=C1 XEHNLVMHWYPNEQ-UHFFFAOYSA-N 0.000 description 1
- GCTFDMFLLBCLPF-UHFFFAOYSA-N 2,5-dichloropyridine Chemical compound ClC1=CC=C(Cl)N=C1 GCTFDMFLLBCLPF-UHFFFAOYSA-N 0.000 description 1
- CZOZLTKKYXGUOF-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-n-[2-(2,5-dimethoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=C(OC)C(CCNC(=O)CC=2C=C3OCOC3=CC=2)=C1 CZOZLTKKYXGUOF-UHFFFAOYSA-N 0.000 description 1
- YZXVYTKPWJJCEJ-UHFFFAOYSA-N 2-(1-benzhydryl-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=CC=NC=1CNC(=O)CN1CCC=2C(OC)=CC=C(OC)C=2C1C(C=1C=CC=CC=1)C1=CC=CC=C1 YZXVYTKPWJJCEJ-UHFFFAOYSA-N 0.000 description 1
- ZEUTZGFXLORKJQ-UHFFFAOYSA-N 2-(1-benzhydryl-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(C(C=2C=CC=CC=2)C=2C=CC=CC=2)C2=C(OC)C=CC(OC)=C2CC1 ZEUTZGFXLORKJQ-UHFFFAOYSA-N 0.000 description 1
- LCXPFNFFURACNW-UHFFFAOYSA-N 2-(1-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-(1-naphthalen-1-ylethyl)acetamide Chemical compound C=1C=CC2=CC=CC=C2C=1C(C)NC(=O)CN1CCC2=CC=CC=C2C1CC1=CC=CC=C1 LCXPFNFFURACNW-UHFFFAOYSA-N 0.000 description 1
- NPGGQDDSLRWGOJ-UHFFFAOYSA-N 2-(1-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-chlorophenyl)methyl]acetamide Chemical compound ClC1=CC=CC=C1CNC(=O)CN1C(CC=2C=CC=CC=2)C2=CC=CC=C2CC1 NPGGQDDSLRWGOJ-UHFFFAOYSA-N 0.000 description 1
- JUOJVMYJTALTKH-UHFFFAOYSA-N 2-(1-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-methylphenyl)methyl]acetamide Chemical compound CC1=CC=CC=C1CNC(=O)CN1C(CC=2C=CC=CC=2)C2=CC=CC=C2CC1 JUOJVMYJTALTKH-UHFFFAOYSA-N 0.000 description 1
- KFWXNFSDXRQIRN-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CCC2)C1CC1=CC=CC=C1 KFWXNFSDXRQIRN-UHFFFAOYSA-N 0.000 description 1
- UTXKRSAEUURBKV-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-(1-naphthalen-1-ylethyl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC(C)C=2C3=CC=CC=C3C=CC=2)C1CC1=CC=CC=C1 UTXKRSAEUURBKV-UHFFFAOYSA-N 0.000 description 1
- AOHGDIAKNFOWEK-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1CC1=CC=CC=C1 AOHGDIAKNFOWEK-UHFFFAOYSA-N 0.000 description 1
- DMKYLYSZUJKKQW-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-(pyridin-3-ylmethyl)acetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CN=C1 DMKYLYSZUJKKQW-UHFFFAOYSA-N 0.000 description 1
- FATDEOJFDRHCNQ-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2,5-difluorophenyl)methyl]acetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC(F)=CC=C1F FATDEOJFDRHCNQ-UHFFFAOYSA-N 0.000 description 1
- YEAZNFSUZWAJFH-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-chlorophenyl)methyl]acetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1Cl YEAZNFSUZWAJFH-UHFFFAOYSA-N 0.000 description 1
- YSOLKWJQSARACF-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(2-methylphenyl)methyl]acetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1C YSOLKWJQSARACF-UHFFFAOYSA-N 0.000 description 1
- RJUGHGUBIPEVPE-UHFFFAOYSA-N 2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-[(4-fluorophenyl)methyl]acetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=C(F)C=C1 RJUGHGUBIPEVPE-UHFFFAOYSA-N 0.000 description 1
- ZMWCKCLDAQWIDA-UHFFFAOYSA-N 2-(2,3,4-trimethoxyphenyl)acetic acid Chemical compound COC1=CC=C(CC(O)=O)C(OC)=C1OC ZMWCKCLDAQWIDA-UHFFFAOYSA-N 0.000 description 1
- GJBVKWQIHCHNBO-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)-n-[2-(2,5-dimethoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=C(OC)C(CCNC(=O)CC=2C(=CC=C(OC)C=2)OC)=C1 GJBVKWQIHCHNBO-UHFFFAOYSA-N 0.000 description 1
- LPXOPDKFARVIQB-UHFFFAOYSA-N 2-(2-methoxy-5-phenylmethoxyphenyl)ethanamine Chemical compound C1=C(CCN)C(OC)=CC=C1OCC1=CC=CC=C1 LPXOPDKFARVIQB-UHFFFAOYSA-N 0.000 description 1
- DDSJXCGGOXKGSJ-UHFFFAOYSA-N 2-(3,4,5-trimethoxyphenyl)acetic acid Chemical compound COC1=CC(CC(O)=O)=CC(OC)=C1OC DDSJXCGGOXKGSJ-UHFFFAOYSA-N 0.000 description 1
- YCAKYFIYUHHCKW-UHFFFAOYSA-N 2-(3,4-difluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(F)C(F)=C1 YCAKYFIYUHHCKW-UHFFFAOYSA-N 0.000 description 1
- CFEHWNSMGUKJEU-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-2-methoxyethanamine Chemical compound COC(CN)C1=CC=C(OC)C(OC)=C1 CFEHWNSMGUKJEU-UHFFFAOYSA-N 0.000 description 1
- NFCIDYJGAZFATM-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(2,3,4-trimethoxyphenyl)ethyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC(=O)NCCC1=CC=C(OC)C(OC)=C1OC NFCIDYJGAZFATM-UHFFFAOYSA-N 0.000 description 1
- LMBCEKZJBDMWCI-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(2,5-dimethoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=C(OC)C(CCNC(=O)CC=2C=C(OC)C(OC)=CC=2)=C1 LMBCEKZJBDMWCI-UHFFFAOYSA-N 0.000 description 1
- BXUQYJBJJMBZDJ-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(3,4,5-trimethoxyphenyl)ethyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC(=O)NCCC1=CC(OC)=C(OC)C(OC)=C1 BXUQYJBJJMBZDJ-UHFFFAOYSA-N 0.000 description 1
- KEOYZVLRUGFKRP-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(3,5-dimethoxyphenyl)ethyl]acetamide Chemical compound COC1=CC(OC)=CC(CCNC(=O)CC=2C=C(OC)C(OC)=CC=2)=C1 KEOYZVLRUGFKRP-UHFFFAOYSA-N 0.000 description 1
- UXKKZRKCHFAQGX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(3-methoxy-4-propan-2-yloxyphenyl)ethyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC(=O)NCCC1=CC=C(OC(C)C)C(OC)=C1 UXKKZRKCHFAQGX-UHFFFAOYSA-N 0.000 description 1
- ZHSFEDDRTVLPHH-UHFFFAOYSA-N 2-(3,5-dimethoxyphenyl)ethanamine Chemical compound COC1=CC(CCN)=CC(OC)=C1 ZHSFEDDRTVLPHH-UHFFFAOYSA-N 0.000 description 1
- HCOOZGAXYIYHQX-UHFFFAOYSA-N 2-(3-benzoyloxy-4-methoxyphenyl)acetic acid Chemical compound COC1=C(C=C(C=C1)CC(=O)O)OC(=O)C2=CC=CC=C2 HCOOZGAXYIYHQX-UHFFFAOYSA-N 0.000 description 1
- GLMWLELOJCRYRI-UHFFFAOYSA-N 2-(3-methoxy-4-phenylmethoxyphenyl)ethanamine Chemical compound COC1=CC(CCN)=CC=C1OCC1=CC=CC=C1 GLMWLELOJCRYRI-UHFFFAOYSA-N 0.000 description 1
- HJGNAXXDNNYRNN-UHFFFAOYSA-N 2-(3-methoxy-4-propan-2-yloxyphenyl)ethanamine Chemical compound COC1=CC(CCN)=CC=C1OC(C)C HJGNAXXDNNYRNN-UHFFFAOYSA-N 0.000 description 1
- UZUYKYNVSJTWEH-UHFFFAOYSA-N 2-(3-methoxyphenyl)acetyl chloride Chemical compound COC1=CC=CC(CC(Cl)=O)=C1 UZUYKYNVSJTWEH-UHFFFAOYSA-N 0.000 description 1
- WJBMRZAHTUFBGE-UHFFFAOYSA-N 2-(3-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC(CCN)=C1 WJBMRZAHTUFBGE-UHFFFAOYSA-N 0.000 description 1
- UMQUIRYNOVNYPA-UHFFFAOYSA-N 2-(4-chlorophenyl)acetyl chloride Chemical compound ClC(=O)CC1=CC=C(Cl)C=C1 UMQUIRYNOVNYPA-UHFFFAOYSA-N 0.000 description 1
- MGKPFALCNDRSQD-UHFFFAOYSA-N 2-(4-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(F)C=C1 MGKPFALCNDRSQD-UHFFFAOYSA-N 0.000 description 1
- HGPYIHOTQGSJAJ-UHFFFAOYSA-N 2-(4-methoxy-3-phenylmethoxyphenyl)ethanamine Chemical compound COC1=CC=C(CCN)C=C1OCC1=CC=CC=C1 HGPYIHOTQGSJAJ-UHFFFAOYSA-N 0.000 description 1
- CXJOONIFSVSFAD-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(CC(Cl)=O)C=C1 CXJOONIFSVSFAD-UHFFFAOYSA-N 0.000 description 1
- UPPFDZBHJOPNAI-UHFFFAOYSA-N 2-(5-methoxy-2-phenylmethoxyphenyl)ethanamine Chemical compound NCCC1=CC(OC)=CC=C1OCC1=CC=CC=C1 UPPFDZBHJOPNAI-UHFFFAOYSA-N 0.000 description 1
- ULWOQYXTZAOOPO-GEVKEYJPSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 ULWOQYXTZAOOPO-GEVKEYJPSA-N 0.000 description 1
- YVHFWLYZVUCPFZ-VWLOTQADSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-phenylethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCCC1=CC=CC=C1 YVHFWLYZVUCPFZ-VWLOTQADSA-N 0.000 description 1
- BFYOCLKGJYHCMY-NDEPHWFRSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC2=CC=CC=C12 BFYOCLKGJYHCMY-NDEPHWFRSA-N 0.000 description 1
- KEWALFLCFJBWCO-QHCPKHFHSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=N1 KEWALFLCFJBWCO-QHCPKHFHSA-N 0.000 description 1
- FNNMZALNMKRGEM-AKOVUPKNSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)N[C@@H]1C2=CC=CC=C2C[C@@H]1O FNNMZALNMKRGEM-AKOVUPKNSA-N 0.000 description 1
- FNNMZALNMKRGEM-NTWBYJAHSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)N[C@H]1C2=CC=CC=C2C[C@H]1O FNNMZALNMKRGEM-NTWBYJAHSA-N 0.000 description 1
- LHFABXXKENNWII-DEOSSOPVSA-N 2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1[C@@H](CC=2C=C(OC)C(OC)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 LHFABXXKENNWII-DEOSSOPVSA-N 0.000 description 1
- QMSCUOPGILYJHS-UHFFFAOYSA-N 2-[1-(1,3-benzodioxol-5-ylmethyl)-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,3,4-thiadiazol-2-yl)acetamide Chemical compound C1CC=2C(OC)=CC=C(OC)C=2C(CC=2C=C3OCOC3=CC=2)N1CC(=O)NC1=NN=CS1 QMSCUOPGILYJHS-UHFFFAOYSA-N 0.000 description 1
- SJFYJJPNSJYFTF-UHFFFAOYSA-N 2-[1-(1,3-benzodioxol-5-ylmethyl)-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1CC=2C(OC)=CC=C(OC)C=2C(CC=2C=C3OCOC3=CC=2)N1CC(=O)NCC1=CC=CC=N1 SJFYJJPNSJYFTF-UHFFFAOYSA-N 0.000 description 1
- PSMVBRYVVNJIGG-UHFFFAOYSA-N 2-[1-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C2OCOC2=CC(CC2N(CC(=O)NC3C4=CC=CC=C4CC3)CCC=3C=C(C(=CC=32)OC)OC)=C1 PSMVBRYVVNJIGG-UHFFFAOYSA-N 0.000 description 1
- WPGGXCQKSBFHJC-UHFFFAOYSA-N 2-[1-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-2-yl)acetamide Chemical compound C1=C2OCOC2=CC(CC2N(CC(=O)NC3CC4=CC=CC=C4C3)CCC=3C=C(C(=CC=32)OC)OC)=C1 WPGGXCQKSBFHJC-UHFFFAOYSA-N 0.000 description 1
- IXRWCEBQQWJXKQ-LERNEWSCSA-N 2-[1-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C2OCOC2=CC(CC2N(CC(=O)N[C@@H]3C4=CC=CC=C4C[C@@H]3O)CCC=3C=C(C(=CC=32)OC)OC)=C1 IXRWCEBQQWJXKQ-LERNEWSCSA-N 0.000 description 1
- QONDXCRQUGCFSH-UHFFFAOYSA-N 2-[1-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-benzylacetamide Chemical compound C=1C=C2OCOC2=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 QONDXCRQUGCFSH-UHFFFAOYSA-N 0.000 description 1
- RMTSROMBLYUNSJ-ZUPBRTMSSA-N 2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2CC(=O)N[C@@H]2C3=CC=CC=C3C[C@@H]2O)=C1 RMTSROMBLYUNSJ-ZUPBRTMSSA-N 0.000 description 1
- RMTSROMBLYUNSJ-BXZZTTDXSA-N 2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2CC(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)=C1 RMTSROMBLYUNSJ-BXZZTTDXSA-N 0.000 description 1
- NXBHJXJJEGBLBZ-UHFFFAOYSA-N 2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C(=CC=C(OC)C=2)OC)C2=C(OC)C=CC(OC)=C2CC1 NXBHJXJJEGBLBZ-UHFFFAOYSA-N 0.000 description 1
- LDDWQXOOILLUNJ-UHFFFAOYSA-N 2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2CC(=O)NCC=2C(=CC=CC=2)OC)=C1 LDDWQXOOILLUNJ-UHFFFAOYSA-N 0.000 description 1
- CBBXHTBAVQHVEY-UHFFFAOYSA-N 2-[1-[(2,5-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-methoxyphenyl)methyl]acetamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)CN1C(CC=2C(=CC=C(OC)C=2)OC)C2=CC(OC)=C(OC)C=C2CC1 CBBXHTBAVQHVEY-UHFFFAOYSA-N 0.000 description 1
- QLARILXXWYNJNT-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 QLARILXXWYNJNT-UHFFFAOYSA-N 0.000 description 1
- LCHQIKYMBXFTNA-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-phenylethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1CC(=O)NCCC1=CC=CC=C1 LCHQIKYMBXFTNA-UHFFFAOYSA-N 0.000 description 1
- DSNMWNPIXDQQAY-BGCJDWCDSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1CC(=O)N[C@@H]1C2=CC=CC=C2C[C@@H]1O DSNMWNPIXDQQAY-BGCJDWCDSA-N 0.000 description 1
- DSNMWNPIXDQQAY-RJMZRKIXSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1CC(=O)N[C@H]1C2=CC=CC=C2C[C@H]1O DSNMWNPIXDQQAY-RJMZRKIXSA-N 0.000 description 1
- YIKHWMJNPGLANX-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C(C=C(OC)C(OC)=C2OC)=C2CC1 YIKHWMJNPGLANX-UHFFFAOYSA-N 0.000 description 1
- CRNHNXCNFIUMML-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C(C=C(OC)C(OC)=C2OC)=C2CC1 CRNHNXCNFIUMML-UHFFFAOYSA-N 0.000 description 1
- WJFLADFGDHIOSZ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,3,4-thiadiazol-2-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC)=C2CCN1CC(=O)NC1=NN=CS1 WJFLADFGDHIOSZ-UHFFFAOYSA-N 0.000 description 1
- WRZDXSGMSPBJNK-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-fluorophenyl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=C1F WRZDXSGMSPBJNK-UHFFFAOYSA-N 0.000 description 1
- UAXSWNJARCKBRP-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=C(OC)C=CC(OC)=C2CC1 UAXSWNJARCKBRP-UHFFFAOYSA-N 0.000 description 1
- ZDXNJKFVLJAFOZ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5-(2-fluoroethoxy)-8-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OCCF)=C2CCN1CC(=O)NCC1=CC=CC=N1 ZDXNJKFVLJAFOZ-UHFFFAOYSA-N 0.000 description 1
- GQLRRVJKVGBGJQ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-5-(3-fluoropropoxy)-8-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OCCCF)=C2CCN1CC(=O)NCC1=CC=CC=N1 GQLRRVJKVGBGJQ-UHFFFAOYSA-N 0.000 description 1
- BPRRWWINTJTZBT-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 BPRRWWINTJTZBT-UHFFFAOYSA-N 0.000 description 1
- ZPAUIZYCDVBPDX-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-phenylethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)NCCC1=CC=CC=C1 ZPAUIZYCDVBPDX-UHFFFAOYSA-N 0.000 description 1
- LLAJYOGNTGGLAL-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC2=CC=CC=C12 LLAJYOGNTGGLAL-UHFFFAOYSA-N 0.000 description 1
- IFKMDTZYNYRYAK-LERNEWSCSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)N[C@@H]1C2=CC=CC=C2C[C@@H]1O IFKMDTZYNYRYAK-LERNEWSCSA-N 0.000 description 1
- IFKMDTZYNYRYAK-CYFLPILUSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)N[C@H]1C2=CC=CC=C2C[C@H]1O IFKMDTZYNYRYAK-CYFLPILUSA-N 0.000 description 1
- XOUZUPVUUGVHAR-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=C(OC)C(OC)=C(OC)C=C2CC1 XOUZUPVUUGVHAR-UHFFFAOYSA-N 0.000 description 1
- KGOMKWWWGVLEJL-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=C(OC)C(OC)=C(OC)C=C2CC1 KGOMKWWWGVLEJL-UHFFFAOYSA-N 0.000 description 1
- RFLDPFAMNOUWGV-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1-naphthalen-1-ylethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC(C)C1=CC=CC2=CC=CC=C12 RFLDPFAMNOUWGV-UHFFFAOYSA-N 0.000 description 1
- CGJUYBOMSUNTIS-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1C CGJUYBOMSUNTIS-UHFFFAOYSA-N 0.000 description 1
- KMUGTAJITDVKMG-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(5,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC(C)=CC(C)=C2CCC1 KMUGTAJITDVKMG-UHFFFAOYSA-N 0.000 description 1
- QEGOARXJHHXUDY-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(furan-2-yl)propanamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1C(C)C(=O)NC1=CC=CO1 QEGOARXJHHXUDY-UHFFFAOYSA-N 0.000 description 1
- WIERBVPMWIMPQC-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-fluorophenyl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1F WIERBVPMWIMPQC-UHFFFAOYSA-N 0.000 description 1
- ZQXGAZFIRYBSJF-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-methoxyphenyl)methyl]acetamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 ZQXGAZFIRYBSJF-UHFFFAOYSA-N 0.000 description 1
- NPBJMBYFVMURHZ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-methylphenyl)methyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=C(C)C=C1 NPBJMBYFVMURHZ-UHFFFAOYSA-N 0.000 description 1
- YZSRWQVBWWKMCZ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[2-(4-methoxyphenyl)ethyl]acetamide Chemical compound C1=CC(OC)=CC=C1CCNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 YZSRWQVBWWKMCZ-UHFFFAOYSA-N 0.000 description 1
- YNDPHYSINPVSPS-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=2C(OC)=CC(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CCC2)C1CC1=CC=C(OC)C(OC)=C1 YNDPHYSINPVSPS-UHFFFAOYSA-N 0.000 description 1
- DDXQUVGQZPOYFJ-ZUPBRTMSSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=2C(OC)=CC(OC)=CC=2CCN(CC(=O)N[C@@H]2C3=CC=CC=C3C[C@@H]2O)C1CC1=CC=C(OC)C(OC)=C1 DDXQUVGQZPOYFJ-ZUPBRTMSSA-N 0.000 description 1
- DDXQUVGQZPOYFJ-BXZZTTDXSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=2C(OC)=CC(OC)=CC=2CCN(CC(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C1CC1=CC=C(OC)C(OC)=C1 DDXQUVGQZPOYFJ-BXZZTTDXSA-N 0.000 description 1
- QBEYTWHWIXHQJE-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=C(OC)C=C(OC)C=C2CC1 QBEYTWHWIXHQJE-UHFFFAOYSA-N 0.000 description 1
- CVNYSFJBKISKQS-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C(OC)=CC(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1OC CVNYSFJBKISKQS-UHFFFAOYSA-N 0.000 description 1
- KSMXYSIQEPCATA-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1CCC2=CC=CC=C2C1NC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 KSMXYSIQEPCATA-UHFFFAOYSA-N 0.000 description 1
- VIUJCBPPZFUERD-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical compound C=1C=CC2=CC=CC=C2C=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 VIUJCBPPZFUERD-UHFFFAOYSA-N 0.000 description 1
- NFLWXDNHJVPSHU-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-3-ylmethyl)acetamide Chemical compound C=1C=CN=CC=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 NFLWXDNHJVPSHU-UHFFFAOYSA-N 0.000 description 1
- MJCLZUWOLGLTJO-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-4-ylmethyl)acetamide Chemical compound C=1C=NC=CC=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 MJCLZUWOLGLTJO-UHFFFAOYSA-N 0.000 description 1
- IBBDYVJZLQTWBY-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-fluorophenyl)methyl]acetamide Chemical compound C=1C=CC=C(F)C=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 IBBDYVJZLQTWBY-UHFFFAOYSA-N 0.000 description 1
- KEGPKYXRXFQHPW-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound C=1C=CC=C(OC)C=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 KEGPKYXRXFQHPW-UHFFFAOYSA-N 0.000 description 1
- IQTLSYMDRYQNTO-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(3-methylphenyl)methyl]acetamide Chemical compound C=1C=CC(C)=CC=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 IQTLSYMDRYQNTO-UHFFFAOYSA-N 0.000 description 1
- RAVXHWWHOVARHT-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(4-methoxyphenyl)methyl]acetamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=CC=C(OC)C=C2CC1 RAVXHWWHOVARHT-UHFFFAOYSA-N 0.000 description 1
- VDTJHXAWKKPIDZ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-methyl-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1C VDTJHXAWKKPIDZ-UHFFFAOYSA-N 0.000 description 1
- FRYQWDRRVBEWQB-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-phenylethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NCCC1=CC=CC=C1 FRYQWDRRVBEWQB-UHFFFAOYSA-N 0.000 description 1
- PQMGDVYJAODJPD-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(3-methyl-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2C(C)C1 PQMGDVYJAODJPD-UHFFFAOYSA-N 0.000 description 1
- ZYERDVSIRAQXIK-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(3-phenyl-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2C(C=2C=CC=CC=2)C1 ZYERDVSIRAQXIK-UHFFFAOYSA-N 0.000 description 1
- ALJVQXUINFCSIO-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(4-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2C(C)CC1 ALJVQXUINFCSIO-UHFFFAOYSA-N 0.000 description 1
- NNRVPQIYOJUZOL-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(5,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC(C)=CC(C)=C2CCC1 NNRVPQIYOJUZOL-UHFFFAOYSA-N 0.000 description 1
- DXVOIAKSCNMVLQ-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(5-fluoro-2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=C(F)C=C2CC1 DXVOIAKSCNMVLQ-UHFFFAOYSA-N 0.000 description 1
- ZXSPVIAUGROIDF-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(6,7,8,9-tetrahydro-5h-benzo[7]annulen-5-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCCC1 ZXSPVIAUGROIDF-UHFFFAOYSA-N 0.000 description 1
- QGWVWJLZFXFLFX-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC2=CC=CC=C12 QGWVWJLZFXFLFX-UHFFFAOYSA-N 0.000 description 1
- CSPLRVSCMFPHEN-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=N1 CSPLRVSCMFPHEN-UHFFFAOYSA-N 0.000 description 1
- AXVHTZWYRDFCBM-KEIYTCKESA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)N[C@H]1C2=CC=CC=C2C[C@H]1O AXVHTZWYRDFCBM-KEIYTCKESA-N 0.000 description 1
- YHQXJDDOBCLKSE-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=CC(OC(C)C)=C(OC)C=C2CC1 YHQXJDDOBCLKSE-UHFFFAOYSA-N 0.000 description 1
- OQYCCESSZKHXIN-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-8-(3-fluoropropoxy)-5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OCCCF)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 OQYCCESSZKHXIN-UHFFFAOYSA-N 0.000 description 1
- LDSGDXCQFIJWMN-UHFFFAOYSA-N 2-[1-[(3,4-dimethoxyphenyl)methyl]-8-methoxy-5-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC(C)C)=C2CCN1CC(=O)NCC1=CC=CC=N1 LDSGDXCQFIJWMN-UHFFFAOYSA-N 0.000 description 1
- WVQBRJRAQVIHPT-UHFFFAOYSA-N 2-[1-[(3,4-dimethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-pyridin-2-ylacetamide Chemical compound C=1C=C(C)C(C)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NC1=CC=CC=N1 WVQBRJRAQVIHPT-UHFFFAOYSA-N 0.000 description 1
- BKYLEHQYHMYJRO-UHFFFAOYSA-N 2-[1-[(3,4-dimethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-pyridin-3-ylacetamide Chemical compound C=1C=C(C)C(C)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NC1=CC=CN=C1 BKYLEHQYHMYJRO-UHFFFAOYSA-N 0.000 description 1
- JAUZMBXHXDWZTO-UHFFFAOYSA-N 2-[1-[(3-bromo-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=C(Br)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 JAUZMBXHXDWZTO-UHFFFAOYSA-N 0.000 description 1
- WFLLNZCHRSVGLY-UHFFFAOYSA-N 2-[1-[(3-bromo-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C(Br)C(OC)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 WFLLNZCHRSVGLY-UHFFFAOYSA-N 0.000 description 1
- POTSJECGQSAJMK-UHFFFAOYSA-N 2-[1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1CC1=CC=C(Cl)C=C1 POTSJECGQSAJMK-UHFFFAOYSA-N 0.000 description 1
- HRGLKPPYYZPKHX-UHFFFAOYSA-N 2-[1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-2-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2CC3=CC=CC=C3C2)C1CC1=CC=C(Cl)C=C1 HRGLKPPYYZPKHX-UHFFFAOYSA-N 0.000 description 1
- UPOIFCWTIHRYLN-UHFFFAOYSA-N 2-[1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=C(Cl)C=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=N1 UPOIFCWTIHRYLN-UHFFFAOYSA-N 0.000 description 1
- IARZTVZOWFDFMX-ZZEMQPTCSA-N 2-[1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)N[C@@H]2C3=CC=CC=C3C[C@@H]2O)C1CC1=CC=C(Cl)C=C1 IARZTVZOWFDFMX-ZZEMQPTCSA-N 0.000 description 1
- XUBMRGRNFJLEMC-UHFFFAOYSA-N 2-[1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=CC(Cl)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 XUBMRGRNFJLEMC-UHFFFAOYSA-N 0.000 description 1
- NTPQECKNCONOKW-UHFFFAOYSA-N 2-[1-[(4-fluorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CCC2)C1CC1=CC=C(F)C=C1 NTPQECKNCONOKW-UHFFFAOYSA-N 0.000 description 1
- WLUUNHRKDHGJIT-UHFFFAOYSA-N 2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CCC2)C1CC1=CC=C(N(C)C)C=C1 WLUUNHRKDHGJIT-UHFFFAOYSA-N 0.000 description 1
- OIURQFYVUZKFPA-UHFFFAOYSA-N 2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NCC=2C3=CC=CC=C3C=CC=2)C1CC1=CC=C(N(C)C)C=C1 OIURQFYVUZKFPA-UHFFFAOYSA-N 0.000 description 1
- KDFXGLJGVGZADW-UHFFFAOYSA-N 2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=C(N(C)C)C=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=N1 KDFXGLJGVGZADW-UHFFFAOYSA-N 0.000 description 1
- AUULVZOFBDWUDH-UHFFFAOYSA-N 2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=CC(=CC=2)N(C)C)C2=CC(OC)=C(OC)C=C2CC1 AUULVZOFBDWUDH-UHFFFAOYSA-N 0.000 description 1
- HMTMDNMTEIWDEK-UHFFFAOYSA-N 2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=CC(=CC=2)N(C)C)C2=CC(OC)=C(OC)C=C2CC1 HMTMDNMTEIWDEK-UHFFFAOYSA-N 0.000 description 1
- KQGHTOZUPICELS-UHFFFAOYSA-N 2-[4-(dimethylamino)phenyl]acetic acid Chemical compound CN(C)C1=CC=C(CC(O)=O)C=C1 KQGHTOZUPICELS-UHFFFAOYSA-N 0.000 description 1
- MRZPYZMMPJYLIZ-UHFFFAOYSA-N 2-[5-(2,2-difluoroethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-8-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OCC(F)F)=C2CCN1CC(=O)NCC1=CC=CC=N1 MRZPYZMMPJYLIZ-UHFFFAOYSA-N 0.000 description 1
- WNXKYQDXSCPULT-UHFFFAOYSA-N 2-[5-(cyclopropylmethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-8-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OCC3CC3)=C2CCN1CC(=O)NCC1=CC=CC=N1 WNXKYQDXSCPULT-UHFFFAOYSA-N 0.000 description 1
- LXFSULOWZDZFSE-UHFFFAOYSA-N 2-[5-butan-2-yloxy-1-[(3,4-dimethoxyphenyl)methyl]-8-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=CC=NC=1CNC(=O)CN1CCC=2C(OC(C)CC)=CC=C(OC)C=2C1CC1=CC=C(OC)C(OC)=C1 LXFSULOWZDZFSE-UHFFFAOYSA-N 0.000 description 1
- XZZHDKSKEYPZIG-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-(1-phenylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=CC=CC=1C(CC)C(C1=CC(OC)=C(OC)C=C1CC1)N1CC(=O)NCC1=CC=CC=N1 XZZHDKSKEYPZIG-UHFFFAOYSA-N 0.000 description 1
- PVFHAPFJESRDSQ-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-(2-phenylethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-3-ylmethyl)acetamide Chemical compound C=1C=CC=CC=1CCC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CN=C1 PVFHAPFJESRDSQ-UHFFFAOYSA-N 0.000 description 1
- VKJVVFPYINZHJF-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-(2-phenylethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-fluorophenyl)methyl]acetamide Chemical compound C=1C=CC=CC=1CCC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1F VKJVVFPYINZHJF-UHFFFAOYSA-N 0.000 description 1
- HRWTZZWRTXUSJN-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=C2C=CC=CC2=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=N1 HRWTZZWRTXUSJN-UHFFFAOYSA-N 0.000 description 1
- QHKQPXWKAQCNCL-LMALLOCISA-N 2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=CC=CC2=CC(CC3N(CC(=O)N[C@@H]4C5=CC=CC=C5C[C@@H]4O)CCC=4C=C(C(=CC=43)OC)OC)=CC=C21 QHKQPXWKAQCNCL-LMALLOCISA-N 0.000 description 1
- QHKQPXWKAQCNCL-KINDNZPOSA-N 2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=CC=CC2=CC(CC3N(CC(=O)N[C@H]4C5=CC=CC=C5C[C@H]4O)CCC=4C=C(C(=CC=43)OC)OC)=CC=C21 QHKQPXWKAQCNCL-KINDNZPOSA-N 0.000 description 1
- GTZSDWOUAWXWRE-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C3C=CC=CC3=CC=2)C2=CC(OC)=C(OC)C=C2CC1 GTZSDWOUAWXWRE-UHFFFAOYSA-N 0.000 description 1
- REHNJBABXRYQAU-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C=C3C=CC=CC3=CC=2)C2=CC(OC)=C(OC)C=C2CC1 REHNJBABXRYQAU-UHFFFAOYSA-N 0.000 description 1
- NOIUMTNQHNCKGU-BGCJDWCDSA-N 2-[6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)N[C@@H]2C3=CC=CC=C3C[C@@H]2O)C1CC1=CC=C(OC)C(OC)=C1OC NOIUMTNQHNCKGU-BGCJDWCDSA-N 0.000 description 1
- AFJAASWJKXNGFN-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CCC2)C1CC1=CC=C(OC)C(OC)=C1OC AFJAASWJKXNGFN-UHFFFAOYSA-N 0.000 description 1
- MZLWVWSSAXTNOG-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2-phenylethyl)acetamide Chemical compound C=1C=C(OC)C(OC)=C(OC)C=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCCC1=CC=CC=C1 MZLWVWSSAXTNOG-UHFFFAOYSA-N 0.000 description 1
- LRRYWDRLFAGGED-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C(=C(OC)C(OC)=CC=2)OC)C2=CC(OC)=C(OC)C=C2CC1 LRRYWDRLFAGGED-UHFFFAOYSA-N 0.000 description 1
- OVWHAMLKJHWXFY-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(=O)CN1C(CC=2C(=C(OC)C(OC)=CC=2)OC)C2=CC(OC)=C(OC)C=C2CC1 OVWHAMLKJHWXFY-UHFFFAOYSA-N 0.000 description 1
- JPLVHNIIYBDITA-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NC2C3=CC=CC=C3CCC2)=C1 JPLVHNIIYBDITA-UHFFFAOYSA-N 0.000 description 1
- LEXKBESTYVYDOQ-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-(naphthalen-1-ylmethyl)acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C3=CC=CC=C3C=CC=2)=C1 LEXKBESTYVYDOQ-UHFFFAOYSA-N 0.000 description 1
- YOFNGHNWEITSRA-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-3-ylmethyl)acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=NC=CC=2)=C1 YOFNGHNWEITSRA-UHFFFAOYSA-N 0.000 description 1
- WWMOHOKQBBBFHP-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-fluorophenyl)methyl]acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C(=CC=CC=2)F)=C1 WWMOHOKQBBBFHP-UHFFFAOYSA-N 0.000 description 1
- MKUYADOSHACRDG-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C(=CC=CC=2)OC)=C1 MKUYADOSHACRDG-UHFFFAOYSA-N 0.000 description 1
- QTSMHKPVWMBLAQ-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(3-methylphenyl)methyl]acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=C(C)C=CC=2)=C1 QTSMHKPVWMBLAQ-UHFFFAOYSA-N 0.000 description 1
- BRJPLNJGQJJJRM-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-(2-naphthalen-1-ylethyl)acetamide Chemical compound COC1=CC=C(C=C1)CC2C3=CC(=C(C=C3CCN2CC(=O)NCCC4=CC=CC5=CC=CC=C54)OC)OC BRJPLNJGQJJJRM-UHFFFAOYSA-N 0.000 description 1
- LLEOKICVYDALQN-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide Chemical compound C1=CC(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CCC1 LLEOKICVYDALQN-UHFFFAOYSA-N 0.000 description 1
- OEDCHKKFIPRVKV-UHFFFAOYSA-N 2-[6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]-n-[(2-fluorophenyl)methyl]acetamide Chemical compound C1=CC(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1F OEDCHKKFIPRVKV-UHFFFAOYSA-N 0.000 description 1
- DBVLOSLXGFOHED-UHFFFAOYSA-N 2-[7-(cyclopropylmethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCC3CC3)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 DBVLOSLXGFOHED-UHFFFAOYSA-N 0.000 description 1
- KEINOHDDHOISHL-UHFFFAOYSA-N 2-[8-butan-2-yloxy-1-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C(OC(C)CC)=CC=C(OC)C=2CCN1CC(=O)NCC1=CC=CC=N1 KEINOHDDHOISHL-UHFFFAOYSA-N 0.000 description 1
- MQKCKWYIMXAMBS-UHFFFAOYSA-N 2-[8-cyclohexyloxy-1-[(3,4-dimethoxyphenyl)methyl]-5-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-(pyridin-2-ylmethyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC3CCCCC3)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=N1 MQKCKWYIMXAMBS-UHFFFAOYSA-N 0.000 description 1
- RXNZFHIEDZEUQM-UHFFFAOYSA-N 2-bromo-1,3-thiazole Chemical compound BrC1=NC=CS1 RXNZFHIEDZEUQM-UHFFFAOYSA-N 0.000 description 1
- FZRBTBCCMVNZBD-UHFFFAOYSA-N 2-chloro-4-(trifluoromethyl)pyrimidine Chemical compound FC(F)(F)C1=CC=NC(Cl)=N1 FZRBTBCCMVNZBD-UHFFFAOYSA-N 0.000 description 1
- JFZJMSDDOOAOIV-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)N=C1 JFZJMSDDOOAOIV-UHFFFAOYSA-N 0.000 description 1
- APRMCBSTMFKLEI-UHFFFAOYSA-N 2-chloro-5-methylpyrimidine Chemical compound CC1=CN=C(Cl)N=C1 APRMCBSTMFKLEI-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- GELVZYOEQVJIRR-UHFFFAOYSA-N 2-chloropyrazine Chemical compound ClC1=CN=CC=N1 GELVZYOEQVJIRR-UHFFFAOYSA-N 0.000 description 1
- NGCALTDFVDXPIU-UHFFFAOYSA-N 2-methylsulfonyl-5-(trifluoromethyl)pyrimidine Chemical compound CS(=O)(=O)C1=NC=C(C(F)(F)F)C=N1 NGCALTDFVDXPIU-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- VIBOGIYPPWLDTI-UHFFFAOYSA-N 2-naphthylacetic acid Chemical compound C1=CC=CC2=CC(CC(=O)O)=CC=C21 VIBOGIYPPWLDTI-UHFFFAOYSA-N 0.000 description 1
- QGXMHCMPIAYMGT-UHFFFAOYSA-N 2-phenylbutanoyl chloride Chemical compound CCC(C(Cl)=O)C1=CC=CC=C1 QGXMHCMPIAYMGT-UHFFFAOYSA-N 0.000 description 1
- QISAUDWTBBNJIR-UHFFFAOYSA-N 2-phenylmethoxyacetyl chloride Chemical compound ClC(=O)COCC1=CC=CC=C1 QISAUDWTBBNJIR-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000005806 3,4,5-trimethoxybenzyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1C([H])([H])* 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- DBGKRUPRGRHEKM-UHFFFAOYSA-N 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]heptanoic acid Chemical compound CCCCC(CC(=O)O)C1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC DBGKRUPRGRHEKM-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- AAYKJFZVFFINFK-UHFFFAOYSA-N 3-methyl-2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2C(C)CC(N)C2=C1 AAYKJFZVFFINFK-UHFFFAOYSA-N 0.000 description 1
- MFEILWXBDBCWKF-UHFFFAOYSA-N 3-phenylpropanoyl chloride Chemical compound ClC(=O)CCC1=CC=CC=C1 MFEILWXBDBCWKF-UHFFFAOYSA-N 0.000 description 1
- ITDVJJVNAASTRS-UHFFFAOYSA-N 4,6-dimethoxy-2-methylsulfonylpyrimidine Chemical compound COC1=CC(OC)=NC(S(C)(=O)=O)=N1 ITDVJJVNAASTRS-UHFFFAOYSA-N 0.000 description 1
- ZHPSNGCLCHWTRG-UHFFFAOYSA-N 4,6-dimethyl-2-methylsulfonylpyrimidine Chemical compound CC1=CC(C)=NC(S(C)(=O)=O)=N1 ZHPSNGCLCHWTRG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZZLCFHIKESPLTH-UHFFFAOYSA-N 4-Methylbiphenyl Chemical compound C1=CC(C)=CC=C1C1=CC=CC=C1 ZZLCFHIKESPLTH-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- JHNRTJRDRWKAIW-UHFFFAOYSA-N 4-chloro-2,6-dimethoxypyrimidine Chemical compound COC1=CC(Cl)=NC(OC)=N1 JHNRTJRDRWKAIW-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- JMXMRMSUOHVHOF-UHFFFAOYSA-N 4-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound COC1=CC=CC2=C1CCC2N JMXMRMSUOHVHOF-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- LTPVSOCPYWDIFU-UHFFFAOYSA-N 4-methoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1 LTPVSOCPYWDIFU-UHFFFAOYSA-N 0.000 description 1
- MHIOXTVALGXETC-UHFFFAOYSA-N 4-methyl-2,3-dihydro-1h-inden-1-amine Chemical compound CC1=CC=CC2=C1CCC2N MHIOXTVALGXETC-UHFFFAOYSA-N 0.000 description 1
- LJUQGASMPRMWIW-UHFFFAOYSA-N 5,6-dimethylbenzimidazole Chemical compound C1=C(C)C(C)=CC2=C1NC=N2 LJUQGASMPRMWIW-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- XPGIBDJXEVAVTO-UHFFFAOYSA-N 5-bromo-2-chloropyrimidine Chemical compound ClC1=NC=C(Br)C=N1 XPGIBDJXEVAVTO-UHFFFAOYSA-N 0.000 description 1
- POTIEZMRLKEJOZ-UHFFFAOYSA-N 5-fluoro-2,3-dihydro-1h-inden-1-amine Chemical compound FC1=CC=C2C(N)CCC2=C1 POTIEZMRLKEJOZ-UHFFFAOYSA-N 0.000 description 1
- VZZFSIFKVARSJZ-UHFFFAOYSA-N 5-methoxy-2-methylsulfonylpyrimidine Chemical compound COC1=CN=C(S(C)(=O)=O)N=C1 VZZFSIFKVARSJZ-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- VYGIPIBKCOYHFK-UHFFFAOYSA-N 6-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound COC1=CC=C2CCC(N)C2=C1 VYGIPIBKCOYHFK-UHFFFAOYSA-N 0.000 description 1
- FMQGLSSKBZCURE-UHFFFAOYSA-N 6-methyl-2,3-dihydro-1h-inden-1-amine Chemical compound CC1=CC=C2CCC(N)C2=C1 FMQGLSSKBZCURE-UHFFFAOYSA-N 0.000 description 1
- UNQYAAAWKOOBFQ-UHFFFAOYSA-N 7-[(4-chlorophenyl)methyl]-8-[4-chloro-3-(trifluoromethoxy)phenoxy]-1-(3-hydroxypropyl)-3-methylpurine-2,6-dione Chemical compound C=1C=C(Cl)C=CC=1CN1C=2C(=O)N(CCCO)C(=O)N(C)C=2N=C1OC1=CC=C(Cl)C(OC(F)(F)F)=C1 UNQYAAAWKOOBFQ-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- 206010000599 Acromegaly Diseases 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 201000009586 Basophil Adenoma Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 238000006407 Bischler-Napieralski reaction Methods 0.000 description 1
- NPRFQLMWEAYLDM-UHFFFAOYSA-N C1CCC2=CC=CC=C12.[F] Chemical compound C1CCC2=CC=CC=C12.[F] NPRFQLMWEAYLDM-UHFFFAOYSA-N 0.000 description 1
- HXTVLHFPXORYFR-UHFFFAOYSA-N COc1cc2CCN(CC(=O)NC3CCCc4ccccc34)C(Cc3ccc4ccccc4c3)c2cc1OC Chemical compound COc1cc2CCN(CC(=O)NC3CCCc4ccccc34)C(Cc3ccc4ccccc4c3)c2cc1OC HXTVLHFPXORYFR-UHFFFAOYSA-N 0.000 description 1
- XHGYRNPSKUGFAA-UHFFFAOYSA-N COc1ccc(CC2N(CC(=O)NC3CCc4ccccc34)CCc3cc(OC)c(Oc4ncc(Br)cn4)cc23)cc1OC Chemical compound COc1ccc(CC2N(CC(=O)NC3CCc4ccccc34)CCc3cc(OC)c(Oc4ncc(Br)cn4)cc23)cc1OC XHGYRNPSKUGFAA-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000024581 Compulsive Personality disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010012239 Delusion Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 101500025902 Homo sapiens Orexin-A Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000028482 Hypothalamic disease Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- KNROBIIRFDHTDM-UHFFFAOYSA-N N-butan-2-yl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]propanamide Chemical compound CCC(C)NC(=O)C(C)N1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC KNROBIIRFDHTDM-UHFFFAOYSA-N 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical class NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 description 1
- 201000005746 Pituitary adenoma Diseases 0.000 description 1
- 206010061538 Pituitary tumour benign Diseases 0.000 description 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 206010036832 Prolactinoma Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000005793 Restless legs syndrome Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000036623 Severe mental retardation Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- QKWJUGPVMYEKGI-UHFFFAOYSA-N [2-[2-(2,3-dihydro-1h-inden-1-ylamino)-2-oxoethyl]-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-7-yl] morpholine-4-carboxylate Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(=O)N3CCOCC3)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 QKWJUGPVMYEKGI-UHFFFAOYSA-N 0.000 description 1
- PVQRNVTVIABXEC-UHFFFAOYSA-N [2-[2-[[2-(3,4-dimethoxyphenyl)acetyl]amino]ethyl]-4-methoxyphenyl] benzoate Chemical compound COC1=CC(=C(C=C1)OC(=O)C2=CC=CC=C2)CCNC(=O)CC3=CC(=C(C=C3)OC)OC PVQRNVTVIABXEC-UHFFFAOYSA-N 0.000 description 1
- QCDWTTVNDWXQJE-UHFFFAOYSA-N [3-[2-[[2-(3,4-dimethoxyphenyl)acetyl]amino]ethyl]-4-methoxyphenyl] benzoate Chemical compound COC1=C(C=C(C=C1)OC(=O)C2=CC=CC=C2)CCNC(=O)CC3=CC(=C(C=C3)OC)OC QCDWTTVNDWXQJE-UHFFFAOYSA-N 0.000 description 1
- LQCIZSIFPJFPFC-UHFFFAOYSA-N [4-[2-[[2-(3,4-dimethoxyphenyl)acetyl]amino]ethyl]-2-methoxyphenyl] benzoate Chemical compound COC1=C(C=C(C=C1)CC(=O)NCCC2=CC(=C(C=C2)OC(=O)C3=CC=CC=C3)OC)OC LQCIZSIFPJFPFC-UHFFFAOYSA-N 0.000 description 1
- PEMKPXTZSMUKSG-UHFFFAOYSA-N [4-[[2-[2-(benzylamino)-2-oxoethyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-1-yl]methyl]-2-methoxyphenyl] morpholine-4-carboxylate Chemical compound C=1C=C(OC(=O)N2CCOCC2)C(OC)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 PEMKPXTZSMUKSG-UHFFFAOYSA-N 0.000 description 1
- PNJSUNGZWIXPBG-UHFFFAOYSA-N [4-[[2-[2-(benzylamino)-2-oxoethyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-1-yl]methyl]-2-methoxyphenyl] n,n-dimethylcarbamate Chemical compound C=1C=C(OC(=O)N(C)C)C(OC)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 PNJSUNGZWIXPBG-UHFFFAOYSA-N 0.000 description 1
- SLWMYTQWERIXBN-UHFFFAOYSA-N [5-[2-[2-(3,4-dimethoxyphenyl)ethylamino]-2-oxoethyl]-2-methoxyphenyl] benzoate Chemical compound COC1=C(C=C(C=C1)CCNC(=O)CC2=CC(=C(C=C2)OC)OC(=O)C3=CC=CC=C3)OC SLWMYTQWERIXBN-UHFFFAOYSA-N 0.000 description 1
- FHELEKUSMIFRPA-UHFFFAOYSA-N [5-[2-[[2-(3,4-dimethoxyphenyl)acetyl]amino]ethyl]-2-methoxyphenyl] benzoate Chemical compound COC1=C(C=C(C=C1)CCNC(=O)CC2=CC(=C(C=C2)OC)OC)OC(=O)C3=CC=CC=C3 FHELEKUSMIFRPA-UHFFFAOYSA-N 0.000 description 1
- KLAJGIMRSBUZTE-UHFFFAOYSA-N [5-[[2-[2-(benzylamino)-2-oxoethyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-1-yl]methyl]-2-methoxyphenyl] n,n-dimethylcarbamate Chemical compound C1=C(OC(=O)N(C)C)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 KLAJGIMRSBUZTE-UHFFFAOYSA-N 0.000 description 1
- SUPZGQZIGFKYJW-UHFFFAOYSA-N [chloro(phenyl)methyl] acetate Chemical compound CC(=O)OC(Cl)C1=CC=CC=C1 SUPZGQZIGFKYJW-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- PTPUOMXKXCCSEN-UHFFFAOYSA-N acetyloxymethyl 2-[2-[2-[5-[3-(acetyloxymethoxy)-2,7-dichloro-6-oxoxanthen-9-yl]-2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]phenoxy]ethoxy]-n-[2-(acetyloxymethoxy)-2-oxoethyl]-4-methylanilino]acetate Chemical compound CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=CC=C(C)C=C1OCCOC1=CC(C2=C3C=C(Cl)C(=O)C=C3OC3=CC(OCOC(C)=O)=C(Cl)C=C32)=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O PTPUOMXKXCCSEN-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 206010053552 allodynia Diseases 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- 125000005054 dihydropyrrolyl group Chemical group [H]C1=C([H])C([H])([H])C([H])([H])N1* 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- TYHRJHFMHFZOPQ-UHFFFAOYSA-N ethyl 2-[4-[[2-[2-(benzylamino)-2-oxoethyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-1-yl]methyl]-2-methoxyphenoxy]acetate Chemical compound C1=C(OC)C(OCC(=O)OCC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 TYHRJHFMHFZOPQ-UHFFFAOYSA-N 0.000 description 1
- GPSXBQXZMMBNSY-UHFFFAOYSA-N ethyl 2-[[2-[2-(benzylamino)-2-oxoethyl]-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-7-yl]oxy]acetate Chemical compound C=1C=CC=CC=1CNC(=O)CN1CCC=2C=C(OC)C(OCC(=O)OCC)=CC=2C1CC1=CC=C(OC)C(OC)=C1 GPSXBQXZMMBNSY-UHFFFAOYSA-N 0.000 description 1
- HUKDCLQQBHRLKP-UHFFFAOYSA-N ethyl 2-[[2-[2-(benzylamino)-2-oxoethyl]-1-[(3,4-dimethoxyphenyl)methyl]-7-methoxy-3,4-dihydro-1h-isoquinolin-6-yl]oxy]acetate Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C=C(OC)C(OCC(=O)OCC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 HUKDCLQQBHRLKP-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000031424 hyperprolactinemia Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 208000018548 hypothalamic dysfunction Diseases 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 1
- 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- RTKHSSVXSRMKRZ-UHFFFAOYSA-N methyl 2-(4-bromopyrimidin-2-yl)acetate Chemical compound COC(=O)CC1=NC=CC(Br)=N1 RTKHSSVXSRMKRZ-UHFFFAOYSA-N 0.000 description 1
- GCYIIFMWMWWCQR-UHFFFAOYSA-N methyl 2-[1-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]cyclohexa-2,4-dien-1-yl]acetate Chemical compound C1CC2=CC(OC)=C(OC)C=C2C(CC=2C=C(OC)C(OC)=CC=2)C1C1(CC(=O)OC)CC=CC=C1 GCYIIFMWMWWCQR-UHFFFAOYSA-N 0.000 description 1
- LWJOPWODBBTNEH-UHFFFAOYSA-N methyl 2-[[2-(1-amino-1-oxo-3-pyridin-2-ylpropan-2-yl)-1-[(3,4-dimethoxyphenyl)methyl]-8-methoxy-3,4-dihydro-1h-isoquinolin-5-yl]oxy]acetate Chemical compound C=1C=CC=NC=1CC(C(N)=O)N1CCC=2C(OCC(=O)OC)=CC=C(OC)C=2C1CC1=CC=C(OC)C(OC)=C1 LWJOPWODBBTNEH-UHFFFAOYSA-N 0.000 description 1
- NHFBYYMNJUMVOT-UHFFFAOYSA-N methyl 2-bromo-2-phenylacetate Chemical compound COC(=O)C(Br)C1=CC=CC=C1 NHFBYYMNJUMVOT-UHFFFAOYSA-N 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- VBIBVIYMYFIUHR-UHFFFAOYSA-N n-(1h-benzimidazol-2-ylmethyl)-2-[1-(1,3-benzodioxol-5-ylmethyl)-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=CC=C2NC(CNC(=O)CN3C(CC=4C=C5OCOC5=CC=4)C=4C(OC)=CC=C(C=4CC3)OC)=NC2=C1 VBIBVIYMYFIUHR-UHFFFAOYSA-N 0.000 description 1
- ZGOZHVMMFOPANH-UHFFFAOYSA-N n-(1h-benzimidazol-2-ylmethyl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC)=C2CCN1CC(=O)NCC1=NC2=CC=CC=C2N1 ZGOZHVMMFOPANH-UHFFFAOYSA-N 0.000 description 1
- QCSROEVSOLEUBM-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-(3,4-dihydro-1h-isoquinolin-2-ylmethyl)-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1CC2=CC=CC=C2CN1CC1N(CC(=O)NC2C3=CC=CC=C3CC2)CCC2=C1C=C(OC)C(OC)=C2 QCSROEVSOLEUBM-UHFFFAOYSA-N 0.000 description 1
- DAKUZEZIXNMGRM-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2CC(=O)NC2C3=CC=CC=C3CC2)=C1 DAKUZEZIXNMGRM-UHFFFAOYSA-N 0.000 description 1
- COCMKRZTVNFZCD-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC)=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 COCMKRZTVNFZCD-UHFFFAOYSA-N 0.000 description 1
- SGOJNXYTHISATO-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]-2-phenylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCC1C(C=1C=CC=CC=1)C(=O)NC1C2=CC=CC=C2CC1 SGOJNXYTHISATO-UHFFFAOYSA-N 0.000 description 1
- GKUYIEWTTSABGQ-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1CC2=CC=CC=C2C1NC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 GKUYIEWTTSABGQ-UHFFFAOYSA-N 0.000 description 1
- OZVYDTXWBSOYOZ-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-(5-methoxypyrimidin-2-yl)oxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound N1=CC(OC)=CN=C1OC(C(=C1)OC)=CC2=C1CCN(CC(=O)NC1C3=CC=CC=C3CC1)C2CC1=CC=C(OC)C(OC)=C1 OZVYDTXWBSOYOZ-UHFFFAOYSA-N 0.000 description 1
- ZIJYGDLIFXNETK-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-(5-methylpyrimidin-2-yl)oxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC=3N=CC(C)=CN=3)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 ZIJYGDLIFXNETK-UHFFFAOYSA-N 0.000 description 1
- DENJIHBMUIDHEK-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-[4-(trifluoromethyl)pyrimidin-2-yl]oxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC=3N=C(C=CN=3)C(F)(F)F)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 DENJIHBMUIDHEK-UHFFFAOYSA-N 0.000 description 1
- CXGRDMHLKSHQJU-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-[5-(trifluoromethyl)pyridin-2-yl]oxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC=3N=CC(=CC=3)C(F)(F)F)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 CXGRDMHLKSHQJU-UHFFFAOYSA-N 0.000 description 1
- INRVNEURNBUHHO-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-pyrimidin-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC=3N=CC=CN=3)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 INRVNEURNBUHHO-UHFFFAOYSA-N 0.000 description 1
- PYEXJPAWLBZMAG-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-(2,6-dimethoxypyrimidin-4-yl)oxy-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=NC(OC)=CC(OC=2C(=CC=3CCN(CC(=O)NC4C5=CC=CC=C5CC4)C(CC=4C=C(OC)C(OC)=CC=4)C=3C=2)OC)=N1 PYEXJPAWLBZMAG-UHFFFAOYSA-N 0.000 description 1
- XDGHTVZGBQYGJP-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-(4,6-dimethoxypyrimidin-2-yl)oxy-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC(OC)=NC(OC=2C(=CC=3CCN(CC(=O)NC4C5=CC=CC=C5CC4)C(CC=4C=C(OC)C(OC)=CC=4)C=3C=2)OC)=N1 XDGHTVZGBQYGJP-UHFFFAOYSA-N 0.000 description 1
- YGJXGLLZMWNQHE-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1CC1=CC=C(C)C(C)=C1 YGJXGLLZMWNQHE-UHFFFAOYSA-N 0.000 description 1
- IODGFGGZLPZUIH-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(4-fluorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1CC1=CC=C(F)C=C1 IODGFGGZLPZUIH-UHFFFAOYSA-N 0.000 description 1
- LTEBTGMBISKCLP-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[(5,6-dimethylbenzimidazol-1-yl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=NC2=CC(C)=C(C)C=C2N1CC1N(CC(=O)NC2C3=CC=CC=C3CC2)CCC2=C1C=C(OC)C(OC)=C2 LTEBTGMBISKCLP-UHFFFAOYSA-N 0.000 description 1
- SMSWLVLGQRUDHX-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC(=O)NC2C3=CC=CC=C3CC2)C1CC1=CC=C(N(C)C)C=C1 SMSWLVLGQRUDHX-UHFFFAOYSA-N 0.000 description 1
- PZXNGFGCRNWSRT-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=CC=CC2=CC(CC3N(CC(=O)NC4C5=CC=CC=C5CC4)CCC=4C=C(C(=CC=43)OC)OC)=CC=C21 PZXNGFGCRNWSRT-UHFFFAOYSA-N 0.000 description 1
- IHIKZZHKYNNQTE-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NC2C3=CC=CC=C3CC2)=C1 IHIKZZHKYNNQTE-UHFFFAOYSA-N 0.000 description 1
- KZVKGPJADMQNID-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-1-yl)-2-[6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=CC(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NC1C2=CC=CC=C2CC1 KZVKGPJADMQNID-UHFFFAOYSA-N 0.000 description 1
- UWYJZEHDTUPZDU-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-2-yl)-2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2CC(=O)NC2CC3=CC=CC=C3C2)=C1 UWYJZEHDTUPZDU-UHFFFAOYSA-N 0.000 description 1
- WXNJKPYDHZDWNN-UHFFFAOYSA-N n-(2,3-dihydro-1h-inden-2-yl)-2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=CC=CC2=CC(CC3N(CC(=O)NC4CC5=CC=CC=C5C4)CCC=4C=C(C(=CC=43)OC)OC)=CC=C21 WXNJKPYDHZDWNN-UHFFFAOYSA-N 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- KCKWPNRETNDMMA-UHFFFAOYSA-N n-(5,6-dimethoxy-2,3-dihydro-1h-inden-1-yl)-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)NC1C2=CC(OC)=C(OC)C=C2CC1 KCKWPNRETNDMMA-UHFFFAOYSA-N 0.000 description 1
- CHRQHQDXAKKRMN-DEOSSOPVSA-N n-(cyclohexylmethyl)-2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1CCCCC1 CHRQHQDXAKKRMN-DEOSSOPVSA-N 0.000 description 1
- SSOWOQCKTBJMET-UHFFFAOYSA-N n-(naphthalen-1-ylmethyl)acetamide Chemical compound C1=CC=C2C(CNC(=O)C)=CC=CC2=C1 SSOWOQCKTBJMET-UHFFFAOYSA-N 0.000 description 1
- SGHBDLOMRUXKQF-FTJBHMTQSA-N n-[(1r)-2,3-dihydro-1h-inden-1-yl]-2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)N[C@H]1C2=CC=CC=C2CC1 SGHBDLOMRUXKQF-FTJBHMTQSA-N 0.000 description 1
- JEQKCODCUDURBW-QXPUDEPPSA-N n-[(1r)-2,3-dihydro-1h-inden-1-yl]-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)N[C@H]1C2=CC=CC=C2CC1 JEQKCODCUDURBW-QXPUDEPPSA-N 0.000 description 1
- JEQKCODCUDURBW-MBMZGMDYSA-N n-[(1s)-2,3-dihydro-1h-inden-1-yl]-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)N[C@@H]1C2=CC=CC=C2CC1 JEQKCODCUDURBW-MBMZGMDYSA-N 0.000 description 1
- MUIWJLWCFBEBPF-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC(OC)=CC=C1CNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 MUIWJLWCFBEBPF-UHFFFAOYSA-N 0.000 description 1
- OSUOYVBTRPUAKJ-UHFFFAOYSA-N n-[(2,5-difluorophenyl)methyl]-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC(F)=CC=C1F OSUOYVBTRPUAKJ-UHFFFAOYSA-N 0.000 description 1
- SODGOGUDPVAERC-UHFFFAOYSA-N n-[(2-chlorophenyl)methyl]-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1Cl SODGOGUDPVAERC-UHFFFAOYSA-N 0.000 description 1
- DYSXPJXIDRWVOA-UHFFFAOYSA-N n-[(2-ethoxyphenyl)methyl]-2-[1-[(4-fluorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(=O)CN1C(CC=2C=CC(F)=CC=2)C2=CC(OC)=C(OC)C=C2CC1 DYSXPJXIDRWVOA-UHFFFAOYSA-N 0.000 description 1
- BJMKLTNBGDDTLM-UHFFFAOYSA-N n-[(2-ethoxyphenyl)methyl]acetamide Chemical compound CCOC1=CC=CC=C1CNC(C)=O BJMKLTNBGDDTLM-UHFFFAOYSA-N 0.000 description 1
- UKDWIXWBWBKHRG-UHFFFAOYSA-N n-[(2-methoxyphenyl)methyl]acetamide Chemical compound COC1=CC=CC=C1CNC(C)=O UKDWIXWBWBKHRG-UHFFFAOYSA-N 0.000 description 1
- JEMCXCMZAJPLLR-UHFFFAOYSA-N n-[2-(2,5-dimethoxyphenyl)ethyl]-2,2-diphenylacetamide Chemical compound COC1=CC=C(OC)C(CCNC(=O)C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 JEMCXCMZAJPLLR-UHFFFAOYSA-N 0.000 description 1
- MDDIUSXQWPNOCY-UHFFFAOYSA-N n-[2-(2,5-dimethoxyphenyl)ethyl]-2-phenylacetamide Chemical compound COC1=CC=C(OC)C(CCNC(=O)CC=2C=CC=CC=2)=C1 MDDIUSXQWPNOCY-UHFFFAOYSA-N 0.000 description 1
- HRQJIGPCAHFWBT-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3,4-dimethylphenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(C)C(C)=C1 HRQJIGPCAHFWBT-UHFFFAOYSA-N 0.000 description 1
- SRZQIAXYDQXDCU-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CN1C(CC=2C=C(OC)C(OC)=CC=2)C2=C(OC)C=CC(OC)=C2CC1 SRZQIAXYDQXDCU-UHFFFAOYSA-N 0.000 description 1
- DWKCRQVVSFBILN-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-[4-(dimethylamino)phenyl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(N(C)C)C=C1 DWKCRQVVSFBILN-UHFFFAOYSA-N 0.000 description 1
- OQSLRUAUSVKVBL-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-naphthalen-2-ylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CC1=CC=C(C=CC=C2)C2=C1 OQSLRUAUSVKVBL-UHFFFAOYSA-N 0.000 description 1
- DPMHQVVAJWFHDT-UHFFFAOYSA-N n-[[2-(trifluoromethyl)phenyl]methyl]acetamide Chemical compound CC(=O)NCC1=CC=CC=C1C(F)(F)F DPMHQVVAJWFHDT-UHFFFAOYSA-N 0.000 description 1
- ZUJDKEDYJUPFAN-UHFFFAOYSA-N n-benzyl-2-(1-benzyl-3,4-dihydro-1h-isoquinolin-2-yl)-n-methylacetamide Chemical compound C1CC2=CC=CC=C2C(CC=2C=CC=CC=2)N1CC(=O)N(C)CC1=CC=CC=C1 ZUJDKEDYJUPFAN-UHFFFAOYSA-N 0.000 description 1
- KVEOIMKMDZAODZ-UHFFFAOYSA-N n-benzyl-2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-n-methylacetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)N(C)CC1=CC=CC=C1 KVEOIMKMDZAODZ-UHFFFAOYSA-N 0.000 description 1
- WQVAQRAJJHVITJ-UHFFFAOYSA-N n-benzyl-2-(1-benzyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)acetamide Chemical compound C=1C=CC=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 WQVAQRAJJHVITJ-UHFFFAOYSA-N 0.000 description 1
- WYRVNRWVHSLADF-VWLOTQADSA-N n-benzyl-2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)N(C)CC1=CC=CC=C1 WYRVNRWVHSLADF-VWLOTQADSA-N 0.000 description 1
- FYSUZYYFUUADES-DEOSSOPVSA-N n-benzyl-2-[(1s)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1C[C@H]1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 FYSUZYYFUUADES-DEOSSOPVSA-N 0.000 description 1
- IJHZXBWMUGHAPB-UHFFFAOYSA-N n-benzyl-2-[1-[(2,5-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC=C(OC)C(CC2C3=C(OC)C=CC(OC)=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 IJHZXBWMUGHAPB-UHFFFAOYSA-N 0.000 description 1
- AVBIPMRGQLHZCE-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-difluorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C=1C=C(F)C(F)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)N(C)CC1=CC=CC=C1 AVBIPMRGQLHZCE-UHFFFAOYSA-N 0.000 description 1
- GXEWUQQANRBOSY-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1CC(=O)N(C)CC1=CC=CC=C1 GXEWUQQANRBOSY-UHFFFAOYSA-N 0.000 description 1
- XRQGDGSTMANWDI-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,6,7-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C(C=C(OC)C(OC)=C2OC)=C2CCN1CC(=O)NCC1=CC=CC=C1 XRQGDGSTMANWDI-UHFFFAOYSA-N 0.000 description 1
- OOHOZHPGLGKEDA-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C=CC(OC)=C2CCN1CC(=O)NCC1=CC=CC=C1 OOHOZHPGLGKEDA-UHFFFAOYSA-N 0.000 description 1
- AJMYJXZKZUXZOM-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)N(C)CC1=CC=CC=C1 AJMYJXZKZUXZOM-UHFFFAOYSA-N 0.000 description 1
- RRHOFONXUCHBRV-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7,8-trimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=C(OC)C(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 RRHOFONXUCHBRV-UHFFFAOYSA-N 0.000 description 1
- WYRVNRWVHSLADF-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)N(C)CC1=CC=CC=C1 WYRVNRWVHSLADF-UHFFFAOYSA-N 0.000 description 1
- RIFKIUVCVLNLNX-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C(OC)=CC(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 RIFKIUVCVLNLNX-UHFFFAOYSA-N 0.000 description 1
- IIDGIVMHSLBQQD-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-(3-fluoropropoxy)-7-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OCCCF)C=C2CCN1CC(=O)NCC1=CC=CC=C1 IIDGIVMHSLBQQD-UHFFFAOYSA-N 0.000 description 1
- UWLWEDNGFORSNG-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-ethoxy-7-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C=C(OC)C(OCC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 UWLWEDNGFORSNG-UHFFFAOYSA-N 0.000 description 1
- FTSPPCVUJGHARL-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1CNC(=O)CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(OC)=C1 FTSPPCVUJGHARL-UHFFFAOYSA-N 0.000 description 1
- QDVAKWOYMQNGGI-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-7-propan-2-yloxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC(C)C)=C(OC)C=C2CCN1CC(=O)N(C)CC1=CC=CC=C1 QDVAKWOYMQNGGI-UHFFFAOYSA-N 0.000 description 1
- AGHFHVDPKLRCGG-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-7-methoxy-6-propoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC)C(OC)=CC=1CC1C=2C=C(OC)C(OCCC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 AGHFHVDPKLRCGG-UHFFFAOYSA-N 0.000 description 1
- CICZEQONYJJENP-UHFFFAOYSA-N n-benzyl-2-[1-[(3,4-dimethylphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(C)C(C)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 CICZEQONYJJENP-UHFFFAOYSA-N 0.000 description 1
- YJNWEXBIPHHTSL-UHFFFAOYSA-N n-benzyl-2-[1-[(3-bromo-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(Br)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 YJNWEXBIPHHTSL-UHFFFAOYSA-N 0.000 description 1
- UJYHOMHRYOPODR-UHFFFAOYSA-N n-benzyl-2-[1-[(3-butan-2-yloxy-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC(C)CC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 UJYHOMHRYOPODR-UHFFFAOYSA-N 0.000 description 1
- KUUWMXNYUJXCJE-UHFFFAOYSA-N n-benzyl-2-[1-[(3-butoxy-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OCCCC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 KUUWMXNYUJXCJE-UHFFFAOYSA-N 0.000 description 1
- XYHISTDQFPBNAJ-UHFFFAOYSA-N n-benzyl-2-[1-[(3-ethoxy-4-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OCC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 XYHISTDQFPBNAJ-UHFFFAOYSA-N 0.000 description 1
- AVILAQPWCGYINS-UHFFFAOYSA-N n-benzyl-2-[1-[(4-butoxy-3-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OCCCC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 AVILAQPWCGYINS-UHFFFAOYSA-N 0.000 description 1
- JNIGEWHHJUPHQM-UHFFFAOYSA-N n-benzyl-2-[1-[(4-chlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(Cl)C=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 JNIGEWHHJUPHQM-UHFFFAOYSA-N 0.000 description 1
- MQFIVYZEVJOKJT-UHFFFAOYSA-N n-benzyl-2-[1-[(4-ethoxy-3-methoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OCC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 MQFIVYZEVJOKJT-UHFFFAOYSA-N 0.000 description 1
- NMRGYXCYUVUXPZ-UHFFFAOYSA-N n-benzyl-2-[1-[(4-fluorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C=1C=C(F)C=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)N(C)CC1=CC=CC=C1 NMRGYXCYUVUXPZ-UHFFFAOYSA-N 0.000 description 1
- JXHXKUFFOLJZPJ-UHFFFAOYSA-N n-benzyl-2-[1-[[3-(3-fluoropropoxy)-4-methoxyphenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OCCCF)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 JXHXKUFFOLJZPJ-UHFFFAOYSA-N 0.000 description 1
- CSASHICNZSIRNV-UHFFFAOYSA-N n-benzyl-2-[1-[[3-(cyclopropylmethoxy)-4-methoxyphenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OCC2CC2)C(OC)=CC=C1CC(C1=CC(OC)=C(OC)C=C1CC1)N1CC(=O)NCC1=CC=CC=C1 CSASHICNZSIRNV-UHFFFAOYSA-N 0.000 description 1
- ZWPWVNIEQXBUHH-UHFFFAOYSA-N n-benzyl-2-[1-[[4-(cyclopropylmethoxy)-3-methoxyphenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OCC2CC2)C(OC)=CC=1CC(C1=CC(OC)=C(OC)C=C1CC1)N1CC(=O)NCC1=CC=CC=C1 ZWPWVNIEQXBUHH-UHFFFAOYSA-N 0.000 description 1
- QZACDTCPTNQFQW-UHFFFAOYSA-N n-benzyl-2-[1-[[4-(dimethylamino)phenyl]methyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(N(C)C)C=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 QZACDTCPTNQFQW-UHFFFAOYSA-N 0.000 description 1
- LUJLYXWGWHWLAQ-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-(1-phenylpropyl)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1C(CC)C(C1=CC(OC)=C(OC)C=C1CC1)N1CC(=O)NCC1=CC=CC=C1 LUJLYXWGWHWLAQ-UHFFFAOYSA-N 0.000 description 1
- CKAOWUYHYJNROO-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]-n-methylacetamide Chemical compound C=1C=C2C=CC=CC2=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)N(C)CC1=CC=CC=C1 CKAOWUYHYJNROO-UHFFFAOYSA-N 0.000 description 1
- MDNUNZHZNHLADX-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C2C=CC=CC2=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 MDNUNZHZNHLADX-UHFFFAOYSA-N 0.000 description 1
- JNXCYSVSHLOHDK-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(2,3,4-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC)C(OC)=C(OC)C=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 JNXCYSVSHLOHDK-UHFFFAOYSA-N 0.000 description 1
- LEMFUGXOSANTBO-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(3-methoxy-4-propan-2-yloxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=C(OC(C)C)C(OC)=CC=1CC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NCC1=CC=CC=C1 LEMFUGXOSANTBO-UHFFFAOYSA-N 0.000 description 1
- GRWLBLTYYHQWLG-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(3-methoxy-4-propoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OCCC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 GRWLBLTYYHQWLG-UHFFFAOYSA-N 0.000 description 1
- MBXBOQPTUMHFIF-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(3-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound COC1=CC=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 MBXBOQPTUMHFIF-UHFFFAOYSA-N 0.000 description 1
- GOYSSFCQMFFHOG-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(4-methoxy-3-propan-2-yloxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC(C)C)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 GOYSSFCQMFFHOG-UHFFFAOYSA-N 0.000 description 1
- RSIFYMWHCQCEJN-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(4-methoxy-3-propoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OCCC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 RSIFYMWHCQCEJN-UHFFFAOYSA-N 0.000 description 1
- CEUYUUKQQOETJF-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(4-methoxy-3-pyrimidin-2-yloxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC=2N=CC=CN=2)C(OC)=CC=C1CC(C1=CC(OC)=C(OC)C=C1CC1)N1CC(=O)NCC1=CC=CC=C1 CEUYUUKQQOETJF-UHFFFAOYSA-N 0.000 description 1
- PVPYGDJQVLVJGW-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=CC(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 PVPYGDJQVLVJGW-UHFFFAOYSA-N 0.000 description 1
- QFHFJDFMLQDNNR-UHFFFAOYSA-N n-benzyl-2-[6,7-dimethoxy-1-[[3-methoxy-4-(2-methylpropoxy)phenyl]methyl]-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OCC(C)C)C(OC)=CC(CC2C3=CC(OC)=C(OC)C=C3CCN2CC(=O)NCC=2C=CC=CC=2)=C1 QFHFJDFMLQDNNR-UHFFFAOYSA-N 0.000 description 1
- XNQFWPGTFFEUEI-UHFFFAOYSA-N n-benzyl-2-[6-(cyclopropylmethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-7-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OCC3CC3)C=C2CCN1CC(=O)NCC1=CC=CC=C1 XNQFWPGTFFEUEI-UHFFFAOYSA-N 0.000 description 1
- PDCPVYJJDNZXGL-UHFFFAOYSA-N n-benzyl-2-[7-(cyclopropylmethoxy)-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC1C2=CC(OCC3CC3)=C(OC)C=C2CCN1CC(=O)NCC1=CC=CC=C1 PDCPVYJJDNZXGL-UHFFFAOYSA-N 0.000 description 1
- DHTZPXOXRVKNMG-UHFFFAOYSA-N n-benzyl-2-[7-butoxy-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1CNC(=O)CN1CCC=2C=C(OC)C(OCCCC)=CC=2C1CC1=CC=C(OC)C(OC)=C1 DHTZPXOXRVKNMG-UHFFFAOYSA-N 0.000 description 1
- LOERCPUSPNVQRA-UHFFFAOYSA-N n-butyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-5,8-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound CCCCNC(=O)CN1CCC2=C(OC)C=CC(OC)=C2C1CC1=CC=C(OC)C(OC)=C1 LOERCPUSPNVQRA-UHFFFAOYSA-N 0.000 description 1
- VJENRZSTPCASRW-UHFFFAOYSA-N n-butyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]-2-phenylacetamide Chemical compound C=1C=CC=CC=1C(C(=O)NCCCC)C1CCC2=CC(OC)=C(OC)C=C2C1CC1=CC=C(OC)C(OC)=C1 VJENRZSTPCASRW-UHFFFAOYSA-N 0.000 description 1
- OUFLLPGKUQIPHY-UHFFFAOYSA-N n-cyclohexyl-2-[6,7-dimethoxy-1-(2-phenylethyl)-3,4-dihydro-1h-isoquinolin-2-yl]acetamide Chemical compound C=1C=CC=CC=1CCC1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NC1CCCCC1 OUFLLPGKUQIPHY-UHFFFAOYSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 208000030459 obsessive-compulsive personality disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 208000030062 persistent idiopathic facial pain Diseases 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 208000021310 pituitary gland adenoma Diseases 0.000 description 1
- 208000017402 pituitary gland disease Diseases 0.000 description 1
- 208000010916 pituitary tumor Diseases 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 208000030153 prolactin-producing pituitary gland adenoma Diseases 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- BHRZNVHARXXAHW-UHFFFAOYSA-N sec-butylamine Chemical compound CCC(C)N BHRZNVHARXXAHW-UHFFFAOYSA-N 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (14)
- 화학식(I) 화합물 또는 제약학적으로 수용가능한 이들의 염:화학식 I[여기서,R1, R2, R3, R4는 시아노, 니트로, 할로겐, 수소, 하이드록시, 저급 알킬, 저급 알케닐, 저급 알콕시, 저급 알케닐옥시, 트리플루오르메틸, 트리플루오르메톡시, 사이클로알킬옥시, 아릴옥시, 아르알킬옥시, 헤테로고리옥시, 헤테로고리알킬옥시, R11CO-, NR12R13CO-, R12R13N-, R11OOC-, R11SO2NH- 혹은 R14-CO-NH-이거나, 또는 R1과 R2, R2와 R3, R3과 R4는 1개 또는 2개의 산소 원자를 보유하는 5각형, 6각형, 7각형 고리를 페닐 고리와 형성할 수 있고;R5는 아릴, 아르알킬, 저급 알케닐, 트리플루오르메틸, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R6은 수소, 아릴, 아르알킬, 저급 알킬, 저급 알케닐, 트리플루오르메틸, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R7과 R8은 독립적으로 수소, 아릴, 아르알킬, 저급 알킬, 저급 알케닐, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R9는 아릴(페닐기 제외), 아르알킬, 저급 알킬, 저급 알케닐, 트리플루오르메틸, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R10은 수소, 아릴, 아르알킬, 저급 알킬, 저급 알케닐, 트리플루오르메틸, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R11은 저급 알킬, 아릴, 아르알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R12와 R13은 독립적으로 수소, 알킬, 사이클로알킬, 아릴, 아르알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R14는 알킬, 아릴, 사이클로알킬, 헤테로고리, R12R13N- 또는 R11O-이며;여기서, 단독 또는 결합된 "저급 알킬" 표현은 C1-8 직쇄 또는 분지쇄 알킬을 의미하고,단독 또는 결합된 "저급 알케닐" 표현은 C2-5 직쇄 또는 분지쇄 알케닐을 의미하며,단독 또는 결합된 "저급 알콕시" 표현은 C1-8 직쇄 또는 분지쇄 알콕시를 의미하고,단독 또는 결합된 "사이클로알킬" 표현은 C1-8 직쇄 또는 분지쇄 알킬로 치환 또는 비치환된 C3-8 사이클로알킬을 의미하며,단독 또는 결합된 "아릴" 표현은 시아노, 할로겐, 하이드록시, C1-8 직쇄 또는 분지쇄 알킬, C2-5 직쇄 또는 분지쇄 알케닐, C1-8 직쇄 또는 분지쇄 알콕시, C2-5 직쇄 또는 분지쇄 알케닐옥시, 트리플루오르메틸, 트리플루오르메톡시, 아미노 및 카르복시로 이루어진 군으로부터 선택된 치환기로 치환 또는 비치환된 페닐 또는 나프틸을 의미하고,단독 또는 결합된 "아르알킬" 표현은 시아노, 할로겐, 하이드록시, C1-8 직쇄 또는 분지쇄 알킬, C2-5 직쇄 또는 분지쇄 알케닐, C1-8 직쇄 또는 분지쇄 알콕시, C2-5 직쇄 또는 분지쇄 알케닐옥시, 트리플루오르메틸, 트리플루오르메톡시, 아미노 및 카르복시로 이루어진 군으로부터 선택된 치환기로 치환 또는 비치환된 페닐 또는 나프틸로부터 선택된 치환기로 치환된 C1-8 직쇄 또는 분지쇄 알킬 또는 C3-8 사이클로알킬을 의미하며,단독 또는 결합된 "헤테로고리" 표현은 할로겐, C1-8 직쇄 또는 분지쇄 알킬, 아미노, 니트로, 시아노, 하이드록시, C1-8 직쇄 또는 분지쇄 알콕시, 카르복시 및 C1-8 직쇄 또는 분지쇄 알킬옥시-카르보닐로 이루어진 군으로부터 선택된 치환기로 치환 또는 비치환되고, 산소, 질소 및 황으로부터 선택되고 동일 또는 상이할 수 있는 1개, 2개 또는 3개의 헤테로원자를 보유하며 포화되거나, 부분적으로 불포화되거나 또는 방향족일 수 있는 5- 내지 10 각형 단일 또는 이중 고리를 의미한다].
- 화학식(Ⅱ) 화합물 또는 제약학적으로 수용가능한 이들의 염:화학식 Ⅱ[여기서,R'1과 R'2는 수소, 하이드록시, 저급 알콕시, 또는 할로겐이거나, 또는 1개 혹은 2개의 산소 원자를 보유하는 5각형, 6각형 혹은 7각형 고리를 페닐 고리와 형성하고;R'3은 아릴, 아르알킬, 저급 알케닐, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R'4는 수소, 아릴, 아르알킬, 저급 알킬, 저급 알케닐, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이고;R'5는 아릴(페닐기 제외), 아르알킬, 저급 알킬, 저급 알케닐, 사이클로알킬, 헤테로고리 또는 헤테로고리-저급 알킬이며;여기서, 단독 또는 결합된 "저급 알킬" 표현은 C1-8 직쇄 또는 분지쇄 알킬을 의미하고,단독 또는 결합된 "저급 알케닐" 표현은 C2-5 직쇄 또는 분지쇄 알케닐을 의미하며,단독 또는 결합된 "저급 알콕시" 표현은 C1-8 직쇄 또는 분지쇄 알콕시를 의미하고,단독 또는 결합된 "사이클로알킬" 표현은 C1-8 직쇄 또는 분지쇄 알킬로 치환 또는 비치환된 C3-8 사이클로알킬을 의미하며,단독 또는 결합된 "아릴" 표현은 시아노, 할로겐, 하이드록시, C1-8 직쇄 또는 분지쇄 알킬, C2-5 직쇄 또는 분지쇄 알케닐, C1-8 직쇄 또는 분지쇄 알콕시, C2-5 직쇄 또는 분지쇄 알케닐옥시, 트리플루오르메틸, 트리플루오르메톡시, 아미노 및 카르복시로 이루어진 군으로부터 선택된 치환기로 치환 또는 비치환된 페닐 또는 나프틸을 의미하고,단독 또는 결합된 "아르알킬" 표현은 시아노, 할로겐, 하이드록시, C1-8 직쇄 또는 분지쇄 알킬, C2-5 직쇄 또는 분지쇄 알케닐, C1-8 직쇄 또는 분지쇄 알콕시, C2-5 직쇄 또는 분지쇄 알케닐옥시, 트리플루오르메틸, 트리플루오르메톡시, 아미노 및 카르복시로 이루어진 군으로부터 선택된 치환기로 치환 또는 비치환된 페닐 또는 나프틸로부터 선택된 치환기로 치환된 C1-8 직쇄 또는 분지쇄 알킬 또는 C3-8 사이클로알킬을 의미하며,단독 또는 결합된 "헤테로고리" 표현은 할로겐, C1-8 직쇄 또는 분지쇄 알킬, 아미노, 니트로, 시아노, 하이드록시, C1-8 직쇄 또는 분지쇄 알콕시, 카르복시 및 C1-8 직쇄 또는 분지쇄 알킬옥시-카르보닐로 이루어진 군으로부터 선택된 치환기로 치환 또는 비치환되고, 산소, 질소 및 황으로부터 선택되고 동일 또는 상이할 수 있는 1개, 2개 또는 3개의 헤테로원자를 보유하며 포화되거나, 부분적으로 불포화되거나 또는 방향족일 수 있는 5- 내지 10 각형 단일 또는 이중 고리를 의미한다].
- 제 1 항 또는 제 2 항에 있어서, 다음에서 선택되는 것을 특징으로 하는 화합물:2-[1-(3,4-디메톡시-벤질)-5,8-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-(사이클로프로필-메톡시)-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-(2-플루오르-에톡시)-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-(2,2-디플루오르-에톡시)-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-에톡시-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-프로폭시-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-알릴옥시-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-8-이소프로폭시-5-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-5-프로폭시-8-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드.2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-벤질-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-나프탈렌-1-일메틸-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(2-메톡시-벤질)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(4-플루오르-벤질)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(6-메톡시-나프탈렌-2-일메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(4-메톡시-나프탈렌-2-일메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(3,6)-디플루오르-벤질)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(1-페닐-에틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-3-일메틸)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(2-메틸-벤질)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(3-메틸-벤질)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(1,2,3,4-테트라하이드로-나프탈렌-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-(피라진-2-일옥시)-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-(티아졸-2-일옥시)-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(5-메톡시-인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(6-메톡시-인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(6-메틸-인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(2-메틸-1,2,3,4-테트라하이드로나프탈렌-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(4-메틸-인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(6-메톡시-인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(6-메틸-인단-1-일)-아세트아마이드;2-{1-[4-(피리미딘-2-일옥시)-3-메톡시-벤질]-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일}-N-벤질-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-(N,N-디메틸카르바모일옥시)-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-(3-플루오르-프로폭시)-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-(2-플루오르-에톡시)-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-(2,2-디플루오르-에톡시)-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-(부트-2-옥시)-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-(사이클로프로필-에톡시)-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-에톡시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-프로폭시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-알릴옥시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-이소프로폭시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(인단-1-일)-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-(1-메틸-프로프-2-옥시)-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-벤질-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-[(1S)-인단-1-일)]-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-6-메톡시-7-이소프로폭시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-벤질-아세트아마이드;2-[(1S)-1-(3,4-디메톡시-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-[(1S)-인단-1-일)]-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-에톡시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-벤질-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-프로폭시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-벤질-아세트아마이드;2-[1-(3,4-디메톡시-벤질)-7-알릴옥시-6-메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-벤질-아세트아마이드;N-벤질-2-[1-(3,4-디메틸-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-아세트아마이드;2-[1-(3,4-디메틸-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-[(1S)-인단-1-일]-아세트아마이드;N-벤질-2-[1-(3,4-디에틸-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-아세트아마이드;2-[1-(3,4-디에틸-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-2-일-메틸)-아세트아마이드;2-[1-(3,4-디에틸-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-3-일-메틸)-아세트아마이드;2-[1-(3,4-디에틸-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-4-일-메틸)-아세트아마이드;2-[1-(3,4-디클로로-벤질)-6,7-디메톡시-3,4-디하이드로-1H-이소퀴놀린-2-일]-N-(피리딘-3-일-메틸)-아세트아마이드.
- Ugi-3-구성성분-응축 반응(Ugi-3-CC)을 이용하여 R6, R7, R9가 수소인 제 1 항에 기재된 화학식(Ⅰ) 화합물의 조합 제조 방법에 있어서, R1, R2, R3, R4, R5가 상기 화학식(Ⅰ)에서 정의한 바와 동일하고 R6이 수소인 화학식(Ⅲ) 화합물을 R7이 수소이고 R8이 상기 화학식(Ⅰ)에서 정의한 바와 동일한 화학식(Ⅳ) 화합물 및 R10이 상기 화학식(Ⅰ)에서 정의한 바와 동일한 화학식(Ⅴ) 화합물을 원-팟(one-pot) 반응시키고, 원하는 경우, 제약학적 활성 화합물을 분리하고, 원하는 경우, 수득된 화합물을 염으로 전환시키는 것을 특징으로 하는 방법:화학식 Ⅲ화학식 Ⅳ화학식 Ⅴ
- 삭제
- 제 1 항 또는 제 2 항에 있어서, 오렉신의 역할과 관련된 비만과 수면 장애를 치료하기 위한 약물로 사용되는 것을 특징으로 하는 화합물.
- 인체를 제외한 개체에서 오렉신 수용체의 길항물질이 필요한 질환이나 이상을 치료 또는 예방하는 방법에 있어서, 제 1 항 또는 제 2항에 따른 화합물 또는 제약학적으로 수용가능한 이들의 염의 효과량을 이를 필요로 하는 개체에 투여하는 것을 특징으로 하는 방법.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0002245 | 2000-03-14 | ||
EPPCT/EP00/02245 | 2000-03-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077016214A Division KR20070087103A (ko) | 2000-03-14 | 2001-03-12 | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020080465A KR20020080465A (ko) | 2002-10-23 |
KR100842698B1 true KR100842698B1 (ko) | 2008-07-01 |
Family
ID=8163870
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077016214A KR20070087103A (ko) | 2000-03-14 | 2001-03-12 | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 |
KR1020027011533A KR100842698B1 (ko) | 2000-03-14 | 2001-03-12 | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077016214A KR20070087103A (ko) | 2000-03-14 | 2001-03-12 | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 |
Country Status (18)
Country | Link |
---|---|
US (1) | US6703392B2 (ko) |
JP (1) | JP4009460B2 (ko) |
KR (2) | KR20070087103A (ko) |
CN (1) | CN100393703C (ko) |
AT (1) | ATE286500T1 (ko) |
AU (2) | AU2001260113B2 (ko) |
BR (1) | BRPI0109200B8 (ko) |
CA (1) | CA2402431C (ko) |
DE (1) | DE60108236T2 (ko) |
ES (1) | ES2234840T3 (ko) |
HU (1) | HU227811B1 (ko) |
IL (2) | IL150986A0 (ko) |
MX (1) | MXPA02008797A (ko) |
NO (1) | NO324932B1 (ko) |
NZ (1) | NZ520624A (ko) |
PT (1) | PT1274687E (ko) |
WO (1) | WO2001068609A1 (ko) |
ZA (1) | ZA200206467B (ko) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6943160B2 (en) * | 2000-11-28 | 2005-09-13 | Smithkline Beecham Plc | Morpholine derivatives as antagonists of orexin receptors |
GB0126292D0 (en) * | 2001-11-01 | 2002-01-02 | Smithkline Beecham Plc | Compounds |
GB0130388D0 (en) * | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
US7279578B2 (en) * | 2002-10-11 | 2007-10-09 | Actelion Pharmaceuticals Ltd. | Sulfonylamino-acetic acid derivatives |
GB0225884D0 (en) * | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
AU2004215409B2 (en) * | 2003-02-24 | 2008-11-20 | Merck Sharp & Dohme Corp. | Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
DE602004021786D1 (de) * | 2003-03-26 | 2009-08-13 | Actelion Pharmaceuticals Ltd | Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten |
US7321065B2 (en) * | 2003-04-18 | 2008-01-22 | The Regents Of The University Of California | Thyronamine derivatives and analogs and methods of use thereof |
WO2004096780A1 (en) * | 2003-04-28 | 2004-11-11 | Actelion Pharmaceuticals Ltd | Quinoxalinone-3- one derivatives as orexin receptor antagonists |
EP1669350B1 (en) | 2003-09-22 | 2012-02-29 | Msd K.K. | Piperidine derivatives |
US20100048513A1 (en) | 2008-08-20 | 2010-02-25 | Hawkins Michael J | Novel inhibitors of chymase |
CA2554205C (en) * | 2004-01-23 | 2013-08-27 | Michael J. Hawkins | Novel inhibitors of chymase |
SI1751111T1 (sl) * | 2004-03-01 | 2015-04-30 | Actelion Pharmaceuticals Ltd. | Substituirani 1,2,3,4-tetrahidroizokinolinski derivati |
EP1734963A4 (en) | 2004-04-02 | 2008-06-18 | Merck & Co Inc | METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER |
EP1814590B2 (en) | 2004-11-01 | 2013-12-11 | Amylin Pharmaceuticals, Inc. | Treatment of obesity and related disorders |
US20060178307A1 (en) * | 2005-01-26 | 2006-08-10 | The Regents Of The University Of California | Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor |
US7501395B2 (en) | 2005-04-25 | 2009-03-10 | Eisai R & D Management Co., Ltd. | Method of screening for antianxiety drugs |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
ES2574014T3 (es) | 2005-05-30 | 2016-06-14 | Msd K.K. | Derivado de piperidina novedoso |
US20100216758A1 (en) | 2005-08-10 | 2010-08-26 | Makoto Ando | Pyridone Compounds |
EP1922336B1 (en) | 2005-08-11 | 2012-11-21 | Amylin Pharmaceuticals, LLC | Hybrid polypeptides with selectable properties |
BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
WO2007024004A1 (ja) | 2005-08-24 | 2007-03-01 | Banyu Pharmaceutical Co., Ltd. | フェニルピリドン誘導体 |
US20090264426A1 (en) | 2005-09-07 | 2009-10-22 | Shunji Sakuraba | Bicyclic aromatic substituted pyridone derivative |
RU2008116844A (ru) | 2005-09-29 | 2009-11-10 | Мерк энд Ко., Инк. (US) | Ацилированные производные спиропиперидина как модуляторы рецептора меланокортина-4 |
CA2625416A1 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
WO2007049798A1 (ja) | 2005-10-27 | 2007-05-03 | Banyu Pharmaceutical Co., Ltd. | 新規ベンゾオキサチイン誘導体 |
AU2006312557B2 (en) | 2005-11-10 | 2011-12-08 | Msd K.K. | Aza-substituted spiro derivative |
ES2376488T3 (es) * | 2006-01-26 | 2012-03-14 | Actelion Pharmaceuticals Ltd. | Antibióticos de tetrahidropirano. |
EA015256B1 (ru) * | 2006-03-15 | 2011-06-30 | Актелион Фармасьютикалз Лтд. | Производные тетрагидроизохинолина для повышения функции памяти |
PL2010493T3 (pl) * | 2006-04-12 | 2016-08-31 | Merck Sharp & Dohme | Pirydyloamidy jako antagoniści kanałów wapniowych typu t |
US7834028B2 (en) | 2006-04-26 | 2010-11-16 | Actelion Pharmaceuticals Ltd. | Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists |
WO2008008517A2 (en) | 2006-07-14 | 2008-01-17 | Merck & Co., Inc. | Bridged diazepan orexin receptor antagonists |
WO2008026149A1 (en) * | 2006-08-28 | 2008-03-06 | Actelion Pharmaceuticals Ltd | 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
EP2698157B1 (en) | 2006-09-22 | 2015-05-20 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
JPWO2008038692A1 (ja) | 2006-09-28 | 2010-01-28 | 萬有製薬株式会社 | ジアリールケチミン誘導体 |
PE20081229A1 (es) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
JP2010513466A (ja) * | 2006-12-22 | 2010-04-30 | アクテリオン ファーマシューティカルズ リミテッド | 5,6,7,8−テトラヒドロ−イミダゾ[1,5−a]ピラジン誘導体 |
US8106086B2 (en) | 2007-04-02 | 2012-01-31 | Msd K.K. | Indoledione derivative |
MX2009010727A (es) * | 2007-04-04 | 2009-10-26 | Hoffmann La Roche | Heterociclos como antagonistas de orexina. |
JP2010527924A (ja) | 2007-05-18 | 2010-08-19 | メルク・シャープ・エンド・ドーム・コーポレイション | オキソ架橋ジアゼパンオレキシン受容体アンタゴニスト |
PL2152690T3 (pl) | 2007-05-23 | 2012-06-29 | Merck Sharp & Dohme | Pirydylo piperydynowi antagoniści receptora oreksyny |
AU2008260647A1 (en) | 2007-05-23 | 2008-12-11 | Merck Sharp & Dohme Corp. | Cyclopropyl pyrrolidine orexin receptor antagonists |
US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
PE20091010A1 (es) * | 2007-10-10 | 2009-08-08 | Actelion Pharmaceuticals Ltd | Derivados de tetrahidroquinolina |
RU2010120671A (ru) * | 2007-10-24 | 2011-11-27 | Мерк Шарп Энд Домэ Корп. (Us) | Гетероциклические фениламидные антагонисты кальциевых каналов т-типа |
EP2227455B1 (en) * | 2007-12-28 | 2011-10-12 | Actelion Pharmaceuticals Ltd. | Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use |
AU2009220605A1 (en) | 2008-03-06 | 2009-09-11 | Msd K.K. | Alkylaminopyridine derivative |
EP2272841A1 (en) | 2008-03-28 | 2011-01-12 | Banyu Pharmaceutical Co., Ltd. | Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
BRPI0912820A2 (pt) | 2008-05-20 | 2015-10-13 | Neurogesx Inc | pró-fármacos de relação hepatoprotetora de acetaminofeno |
AU2009261248A1 (en) | 2008-06-19 | 2009-12-23 | Banyu Pharmaceutical Co., Ltd. | Spirodiamine-diarylketoxime derivative |
CN102076694A (zh) * | 2008-06-25 | 2011-05-25 | 埃科特莱茵药品有限公司 | 5,6,7,8-四氢-咪唑并[1,5-a]吡嗪化合物 |
CA2731358A1 (en) | 2008-07-30 | 2010-02-04 | Banyu Pharmaceutical Co., Ltd. | 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
EP2161266A1 (en) | 2008-08-22 | 2010-03-10 | EVOTEC Neurosciences GmbH | Benzofuran derivatives as orexin receptor antagonists |
CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
CN102271509A (zh) | 2008-10-31 | 2011-12-07 | 默沙东公司 | 用于抗糖尿病药的新型环苯并咪唑衍生物 |
WO2010064212A1 (en) | 2008-12-05 | 2010-06-10 | Actelion Pharmaceuticals Ltd | Method for obtaining an optically pure 1,2,3,4 tetrahydro-isoquinoline derivative |
EP2379547A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
WO2011061318A1 (en) | 2009-11-23 | 2011-05-26 | N.V. Organon | Heterocylic compounds as antagonists of the orexin receptors |
CA2786314A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
WO2011138265A2 (en) | 2010-05-03 | 2011-11-10 | Evotec Ag | Indole and indazole derivatives as orexin receptor antagonists |
WO2011138266A1 (en) | 2010-05-03 | 2011-11-10 | Evotec Ag | Indolizine and imidazopyridine derivatives as orexin receptor antagonists |
EP2402322A1 (en) | 2010-07-02 | 2012-01-04 | Actelion Pharmaceuticals Ltd. | 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN103476258B (zh) | 2011-02-25 | 2017-04-26 | 默沙东公司 | 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物 |
DK2758060T3 (en) | 2011-09-19 | 2018-03-05 | Eth Zuerich | ROR gamma modulators for the treatment of diabetes II complications |
AR088352A1 (es) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina |
WO2013078413A1 (en) * | 2011-11-22 | 2013-05-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modulators of lipid storage |
JP2015525782A (ja) | 2012-08-02 | 2015-09-07 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病性三環式化合物 |
PT2935222T (pt) | 2012-12-21 | 2018-12-10 | Epizyme Inc | Inibidores de prmt5 e seus usos |
MX2015010935A (es) | 2013-02-22 | 2015-10-29 | Merck Sharp & Dohme | Compuestos biciclicos antidiabeticos. |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
EP2781217A1 (en) | 2013-03-18 | 2014-09-24 | ETH Zurich | ROR gamma modulators |
AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
ES2901114T3 (es) | 2014-08-29 | 2022-03-21 | Tes Pharma S R L | Inhibidores de ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa |
CN105198809A (zh) * | 2015-09-24 | 2015-12-30 | 绍兴文理学院 | 一种2-(1-酰亚胺基甲基)-1,2,3,4-四氢异喹啉衍生物及其合成方法与应用 |
CN105418498A (zh) * | 2015-12-30 | 2016-03-23 | 绍兴文理学院 | 一种1,2,3,4-四氢异喹啉衍生物及其合成方法与应用 |
US20190151304A1 (en) | 2016-05-10 | 2019-05-23 | Inserm (Institut National De La Santé Et De La Rechercjae Médicale | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory |
AU2017342083A1 (en) | 2016-10-14 | 2019-04-11 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
US10968232B2 (en) | 2016-12-20 | 2021-04-06 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
AU2019385644A1 (en) | 2018-11-20 | 2021-06-03 | Tes Pharma S.R.L. | Inhibitors of α-Amino-β-carboxymuconic acid semialdehyde decarboxylase |
CN112538100B (zh) * | 2020-12-16 | 2022-06-24 | 河南中医药大学 | 一种从黄柏中提取的具有抗炎活性的异喹啉生物碱苷类化合物及其制备方法与应用 |
US20230391726A1 (en) * | 2022-02-25 | 2023-12-07 | The Katholieke Universiteit Leuven | Dihydroquinazolinones and related analogs for inhibiting yap/taz-tead |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3480714A (en) | 1966-02-07 | 1969-11-25 | Ciba Geigy Corp | N-substituted isoquinolines as antiprotozoal agents |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA205079A (en) * | 1920-10-26 | Nelson Lionel | Gas producer | |
DE204917C (ko) | ||||
DE258817C (ko) | ||||
DE261158C (ko) | ||||
CA110459A (en) * | 1907-12-09 | 1908-02-25 | Charles Albert Keller | Electric furnace |
CA173523A (en) * | 1916-04-01 | 1916-11-28 | Raymond B. Price | Textile material |
CA170679A (en) * | 1916-05-26 | 1916-07-11 | Edwin W. Webb | Car brake |
DD204917A1 (de) * | 1981-12-31 | 1983-12-14 | Gerhard Kempter | Verfahren zur herstellung phenylsubstituierter und benzkondensierter cycloalkylaminoacetanilide |
JPS6153268A (ja) * | 1984-08-24 | 1986-03-17 | Hokuriku Seiyaku Co Ltd | アントラニルアミド誘導体 |
DD261158A1 (de) * | 1987-01-08 | 1988-10-19 | Univ Halle Wittenberg | Verfahren zur herstellung von 2-aminoalkyl-3,4-dihydro-4-oxo-7h-pyrrolo 2.3-d pyrimidinen |
DD258817A1 (de) * | 1987-01-19 | 1988-08-03 | Univ Halle Wittenberg | Verfahren zur herstellung von 2-(aminoalkyl) -pyrimido-4,5'-5,4 pyrrolo 3,2-f 1,4 thiazepinderivaten |
CA2100258C (en) * | 1991-01-11 | 1999-12-14 | Bernard Andre Dumaitre | Acridine derivatives |
ES2116601T3 (es) * | 1993-06-22 | 1998-07-16 | Knoll Ag | Derivados de isoquinolina como agentes terapeuticos. |
JPH07267961A (ja) * | 1994-03-30 | 1995-10-17 | Taisho Pharmaceut Co Ltd | ベンゾフロ[3,2−dピリミジン−4−オン誘導体 |
JPH1095766A (ja) * | 1996-09-19 | 1998-04-14 | Sanwa Kagaku Kenkyusho Co Ltd | アセトアミド誘導体、及びその用途 |
YU23499A (sh) | 1996-11-27 | 2001-07-10 | Pfizer Inc. | Inhibitorski amidi apo-b-sekrecije/mtp-a |
AR016817A1 (es) | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento |
US6372757B1 (en) * | 1998-05-08 | 2002-04-16 | Smithkline Beecham P.L.C. | Phenylurea and phenylthio urea derivatives |
WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
GB9827467D0 (en) | 1998-12-15 | 1999-02-10 | Zeneca Ltd | Chemical compounds |
GB9914015D0 (en) | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
GB9914025D0 (en) | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
JP2003503480A (ja) | 1999-07-06 | 2003-01-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | ニューロン活性を有するn−ヘテロ環誘導体 |
-
2001
- 2001-03-12 HU HU0300207A patent/HU227811B1/hu unknown
- 2001-03-12 AU AU2001260113A patent/AU2001260113B2/en not_active Expired
- 2001-03-12 CN CNB018063268A patent/CN100393703C/zh not_active Expired - Lifetime
- 2001-03-12 BR BRPI0109200A patent/BRPI0109200B8/pt not_active IP Right Cessation
- 2001-03-12 KR KR1020077016214A patent/KR20070087103A/ko active Search and Examination
- 2001-03-12 IL IL15098601A patent/IL150986A0/xx active IP Right Grant
- 2001-03-12 US US10/239,693 patent/US6703392B2/en not_active Expired - Lifetime
- 2001-03-12 AU AU6011301A patent/AU6011301A/xx active Pending
- 2001-03-12 JP JP2001567703A patent/JP4009460B2/ja not_active Expired - Lifetime
- 2001-03-12 PT PT01933685T patent/PT1274687E/pt unknown
- 2001-03-12 DE DE60108236T patent/DE60108236T2/de not_active Expired - Lifetime
- 2001-03-12 KR KR1020027011533A patent/KR100842698B1/ko active IP Right Grant
- 2001-03-12 WO PCT/EP2001/002733 patent/WO2001068609A1/en active IP Right Grant
- 2001-03-12 NZ NZ520624A patent/NZ520624A/xx not_active IP Right Cessation
- 2001-03-12 MX MXPA02008797A patent/MXPA02008797A/es active IP Right Grant
- 2001-03-12 AT AT01933685T patent/ATE286500T1/de active
- 2001-03-12 CA CA002402431A patent/CA2402431C/en not_active Expired - Lifetime
- 2001-03-12 ES ES01933685T patent/ES2234840T3/es not_active Expired - Lifetime
-
2002
- 2002-07-30 IL IL150986A patent/IL150986A/en unknown
- 2002-08-13 ZA ZA200206467A patent/ZA200206467B/en unknown
- 2002-09-11 NO NO20024339A patent/NO324932B1/no not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3480714A (en) | 1966-02-07 | 1969-11-25 | Ciba Geigy Corp | N-substituted isoquinolines as antiprotozoal agents |
Also Published As
Publication number | Publication date |
---|---|
NO20024339D0 (no) | 2002-09-11 |
CN100393703C (zh) | 2008-06-11 |
HUP0300207A2 (en) | 2003-05-28 |
NO324932B1 (no) | 2008-01-07 |
BRPI0109200B8 (pt) | 2021-05-25 |
AU2001260113B2 (en) | 2006-04-06 |
HUP0300207A3 (en) | 2005-07-28 |
CA2402431A1 (en) | 2001-09-20 |
DE60108236T2 (de) | 2005-12-22 |
PT1274687E (pt) | 2005-04-29 |
JP4009460B2 (ja) | 2007-11-14 |
WO2001068609A1 (en) | 2001-09-20 |
JP2003527374A (ja) | 2003-09-16 |
ATE286500T1 (de) | 2005-01-15 |
KR20070087103A (ko) | 2007-08-27 |
BR0109200A (pt) | 2003-06-03 |
NO20024339L (no) | 2002-09-11 |
IL150986A0 (en) | 2003-02-12 |
AU6011301A (en) | 2001-09-24 |
CA2402431C (en) | 2009-10-06 |
KR20020080465A (ko) | 2002-10-23 |
CN1416420A (zh) | 2003-05-07 |
BRPI0109200B1 (pt) | 2015-08-11 |
WO2001068609B1 (en) | 2002-02-21 |
DE60108236D1 (de) | 2005-02-10 |
NZ520624A (en) | 2004-02-27 |
HU227811B1 (en) | 2012-03-28 |
IL150986A (en) | 2007-07-04 |
ZA200206467B (en) | 2003-11-13 |
US6703392B2 (en) | 2004-03-09 |
ES2234840T3 (es) | 2005-07-01 |
MXPA02008797A (es) | 2005-09-08 |
US20030176415A1 (en) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100842698B1 (ko) | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 | |
AU2001260113A1 (en) | 1,2,3,4-tetrahydroisoquinoline derivatives | |
US7192950B2 (en) | Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists | |
EP1521583B1 (en) | 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives | |
US7462634B2 (en) | N-(pyridin-2-yl)-sulfonamide derivatives | |
JP6014154B2 (ja) | ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用 | |
US20060178515A1 (en) | Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists | |
AU2002240855A1 (en) | Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists | |
IL177798A (en) | The compound (R2) –2 - {(S1) –7,6– dimethoxy – 1– [2– (4 – trifluoromethyl – phenyl) –ethyl] –3,4 – dihydro – 1H– isoquinoline – 2 – il} - N -Methyl-2 – Phenyl-acetamide, the pharmaceutical preparations containing it, its use in the preparation of a drug for the treatment or prevention of eating or sleep disorders and the preparation of a salt of a compound of a compound with hydrochloric acid in a crystalline form | |
US20070027157A1 (en) | Quinoxalinone-3-one derivatives as orexin receptor antagonists | |
KR20070046879A (ko) | 5-ht7 수용체 안타고니스트 | |
EP1676844A1 (en) | 5-HT7 receptor antagonists | |
US7211584B2 (en) | 5-HT7 receptor ligands | |
EP1274687B1 (en) | 1,2,3,4- tetrahydroisoquinoline derivatives | |
EP1620409B1 (en) | Quinoxalin-3-one derivatives as orexin receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130614 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140616 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150612 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160621 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170616 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180619 Year of fee payment: 11 |